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Chlordecone 
insecticide that 
insects. This 
CHAPTER I 
INTRODUCTION 
is a polycyclic chlorinated 
was used in the control of 
hydrocarbon 
leaf-eating 
insecticide has been implicated as being 
responsible for neurological signs, liver damage, and 
sterility in male factory workers employed in a plant where 
the agent was manufactured (Cohn et~., 1978). Further 
investigation showed that the James River, which drained 
the Chesapeake Bay, was extensively and seriously 
contaminated. Several investigators (Cohn et~., 1978); 
Cannon et~., 1978; Sanborn et~., 1979; Taylor et~., 
1978) have discovered adverse effects on central nervous 
system (CNS) function such as tremor, headaches, abnormal 
elevation of cerebral spinal fluid pressure, and 
di st urbane es cf vision in other chlordecone exposed 
workers. Similar CNS disturbances have been induced 
experimentally in rodents by chemical means (Chang-Tsui and 
Ho, 1980; Reiter et ~l·, 1977; Deitz~!~' 1979; Tilson et 
~., 1980). 
The mechanism of chlordecone neurotoxicity has been 
attributed to inhibition of mitochondrial and synaptosomal 
mernbrane-bounc sodium-potassium ATPases. Desaiah et al. 
1 
2 
(1980) demonstrated that chlordecone induced a neurotoxic 
effect on a synaptosomal event, but this neurotoxicity 
could be attributed to other related synaptosomal membrane 
phenomena. 
Several investigators (Eroschenko and Place, 1977; 
Good et al., 1965) have observed blocked or impaired 
reproductive function in chlordecone-treated birds and 
rodents. High doses of chlordecone produce overt 
teratogenic effects and a variety of toxic manifestations. 
These include low fetal weight (Chernoff and Rogers, 1976; 
Chernoff et al., 
(Chernoff et ~., 
1979) I 
1979), 
reduced postpartum survival 
developmental abnormalities 
involving skeletal, ureterogenital, and central nervous 
systems (Chernoff and Rogers, 1976) and in 
multigenerational studies, decreased reproductive capacity 
as adults (Chernoff et ~-, 197 9). Despite these studies 
of teratogenic effects at high doses in adults, there 
appear to be no reports of biochemical studies on 
neurotoxicity fror:-. in utero exposure. Given that 
ch lordecone is used extensively in developing countries, 
such studies would have considerable merit. 
Therefore, the objective of this research is to 
examine the effects of maternal chlordecone exposure on 
receptor mediated events in developing rat brain. It is 
3 
proposed that CNS development in the presence of a 
lipophilic chlorinated insecticide such as chlordecone 
results in a significant change in the extent of 
neurotransmitter stimulated synaptic membrane events. To 
investigate 
whether 
this hypothesis, 
receptor-coupled 
this research will determine 
events such as 
phosphatidylinositol turnover, muscarinic and dopaminergic 
receptor binding and endogenous biogenic amine levels are 
altered by in utero exposure to chlordecone and whether 
these changes, if any, persist after clearance of the 
insecticide. 
CHAPTER II 
LITERATURE REVIEW 
Environmental Impact of Pesticides 
Environmental Teratogens 
There is speculation about the magnitude of chemical 
involvement in birth defects and reproductive failure. To 
date, only about 25 chemicals are known to be teratogenic in 
humans, compared to more than 800 in laboratory animals 
(Vernadakis, 1982). It is not known if this discrepancy is 
d~s tc a sreaLc= resietancc of hu~ans to the agents or to 
inability to pinpoint the source of teratogenicity in 
humans. The potential danger is great, however, because 
almost 2000 new chemicals are introduced into the 
environme~t each year (Vernadakis, 1982). 
Many factors play a role in human fetal susceptibility 
to a teratogenic agent. The time of administration during 
the pregnancy is probatly one of the most important factors. 
Che~ical or druc exposure during the first 17 days of 
embryonic life (the period of fertilization and 
implantation) usually results either in death of the embryo 
or total recovery without defects. Exposure from days 18 to 
55 (the embryonic period) corresponds with the period of 
organogenesis and prese~ts the greatest risk of birth 
5 
defects. From 56 days until term (the fetal period) the 
process of organogenesis is complete; however, growth 
retardation or functional deficits (brain damage) may result 
from exposure to a teratogen during this stage of 
development (Berlovki et al., 1983). The age and 
nutritional state of the mother, the route of administration 
of the chemicals, and the size and number of doses also 
affect fetal susceptibility. 
Several 
environmental 
mechanisms exist to reduce fetal exposure 
pollutants. The fetus is protected by 
to 
the 
placenta and maternal detoxification mechanisms. The 
placenta 
reach the 
allows only a small fraction of most chemicals to 
fetus. Transfer across the placenta decreases 
with increasing molecular weight, increasing electrical 
charge, and decreasing lipid solubility. 
The dose reaching the placenta via maternal 
circulation is further reduced by detoxification by the 
liver, excretion by the kidneys and in the bile, an6 binding 
to plasma proteins 
difficult). Peak 
(which makes transplacental transfer more 
circulating concentrations are further 
decreased by deposition of toxicants into maternal storage 
depots, for example, insecticide deposits in adipose tissue. 
6 
Some researchers believe that variation in the dose of 
chemicals that reach the fetus, as determined by the above 
factors, could explain why a particular chemical causes 
birth defects in one animal species but not in another 
(Bungay and Dedrick, 1979). 
Assessment of Toxicity 
The expression "acceptable daily intake" has become 
part of the terminology concerning the assessment of the 
toxicity of pesticide chemicals, and is extensively used to 
denote either a concept or a figure. The concept is based 
on the widely accepted fact that all chemicals are toxic, 
but that their toxicity varies markedly, not only in 
nature, but also in the amount that is required to produce 
signs of toxicity. The figure, when applied to pesticide 
chemicals, provides an indication of the amount that might 
be ingested daily in food, even over a lifetime, without 
appreciable risk to the health of the consumer. The figure 
is derived from the experimental data in laboratory animals 
and/or a~propriate observations in humans available at the 
time of evaluation. 
Although the evaluation of toxicological data rests on 
expert judgment, the type of information required for the 
assessment of toxicity of a pesticide represents a problem 
which is not easily solved. In general, the type of 
7 
information and the procedures which generate it should be 
designed to estimate the maximum no-effect dose. 
The following types of information are usually 
necessary: (a) Biochemical aspects, including the kinetics 
of absorption, tissue distribution, and excretion; 
biological half-life; effect on enzymes; and metabolism. 
( b) Special studies--carcinogenicity, mutagenicity, 
neurotoxicity, potentiation, reproduction, teratogenicity, 
etc. ( c) Acute toxicity--LD50 and other studies mainly 
involving single dosings in several species of experimental 
animals. (d) Short-term studies, which generally include 
classical sub•acute 90-day toxicity tests. These studies 
generally extend from the time of weaning of an animal to 
the time of sexual maturity, usually 3 months in rodents and 
1-2 years in dogs or monkeys; ( e) Long-term studies--usually 
80 weeks in mice and 2 years in rats. Multigenerational 
studies may belons in this category depending on the 
duration of the treatment received by each generation. 
( f) Observations in humans, consisting of 
observations in individuals having had occupational or 
accidental exposure (Vettorazzi, 1975). 
Chlorinated Hydrocarbon Insecticides 
The major classes of pesticides have been grouped as 
"nonpersistent," "moderately persistent," or "persistent" 
(Harris, 
required 
residues 
pesticides 
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1969). "Persistence times" reflect the time 
for 75 to 100 percent diappearance of pesticide 
from the site ·of application. Nonpersistent 
have persistence values of 1 to 12 weeks; 
moderately persistent pesticides, 
persistent pesticides 2 to 5 years. 
environmental conditions. 
1 to 18 months; and 
Persistence varies with 
The chlorinated hydrocarbon insecticides such as 
aldrin, dieldrin, endrin, heptachlor, mirex, and chlordecone 
are prime examples of persistent pesticides. Studies with 
this group have elucidated several important concepts in 
environmental toxicology. First, persistence is not a 
desirable attribute as originally believed. Second, the 
transport and disposition of persistent pesticides is 
affected by physical and biological processes which occur 
from the micro to the global scale. Third, high lipid 
solubility coITbined with chemical and biological stability 
can lead to biological magnification of pesticide residues 
(Goring, 19E7). 
Persistence is primarily a function of physiochemical 
properties of substances. In addition, the 
adsorption/desorption process is one of the most i~portant 
factors controlling the fate of pesticides in soils (EailEy 
and White, 1970). Chlorinated hydrocarbon insecticides are 
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highly soluble in lipids and most organic solvents, but have 
low water solubilities and relatively low vapor pressures. 
studies of the absorption of chlorinated hydrocarbons on 
various soils are difficult because of their low water 
solubility. However, studies show that adsorption of the 
hydrophobic chlorinated hydrocarbons depends strongly on the 
presence of soil organic matter. Once adsorbed, these 
chemicals do not readily desorb (Weber, 1972). Two 
implications are readily apparent: (1) such compounds will 
not leach or diffuse in soil and (2) transport into the 
hydrosphere from contaminated soils will be through erosion 
of soil particles or sediment, not by desorption and 
dissolution. When chlorinated hydrocarbons are poorly 
adsorbed, as in sandy soils, the vaporization loss will be 
significant as compared to that in soils with higher organic 
matter. 
Volatilization of pesticides into the atmosphere from 
water and soils is also a transport route. The volatility 
of a chemical fro~ a soil or from water is a function of its 
vapor pressure, but the actual vaporization rate depends on 
several environmental parameters. Temperature, soil 
properties, soil water content, and other physiochemical 
properties such as water solubility and degree of aasorption 
affect the vaporization rate of pesticides from soil. 
slow 
soil 
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Degradation of the chlorinated hydrocarbons is quite 
as compared to other classes of insecticides, and in 
and water it is mainly due to the action of 
microorganisms. To a lesser extent, chemical reactions and 
photochemical reactions degrade the chlorinated hydrocarbons 
under certain conditions. The "caged" compounds such as 
mirex and chlordecone undergo very little detectable 
degradation (Lichtenstein and Schulze, 1960). 
The bioaccumulation of the chlorinated hydrocarbons is 
well documented by environmental residue data (Edwards, 
1970). Bioaccumulation ratios relate organism residues to 
environmental residue levels and are higher in aquatic 
ecosystems as opposed to terrestrial ecosystems (Acree et 
al., 1963). The processes involved in bioaccumulation are 
quite complex due to the population fluctuations, food web 
relationships, metabolic capabilities of various species and 
numerous other ecologic 
physiochemical parameters 
considerations. However, 
of lipid solubility, lo~ 
the 
water 
solubility, and chen:ical stability, which characterize the 
chlorinated hydrocarbons, appear to be most important in 
bioaccumulation of organic pesticides. 
Chlordecone was used extensively for a variety of 
agricultural pest control purposes and in many public health 
disease control programs worldwide. High levels ·of the 
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compound were applied over wide areas. The result of this 
heavy usage was the widespread contamination of many of the 
components of the environment with residues of chlordecone 
that are likely to persist for many years. Very low levels 
of the insecticide, only marginally detectable in some 
cases, exist in the air, atmospheric dust, and rainwater. 
From there the compound is transported to the soil and water 
ecosystems where it becomes available for a variety of 
organisms. These residues are then bioaccumulated, with man 
sitting atop the food chain as the ultimate consumer. 
Although direct toxicity to humans has not been documented 
as a result of the accumulation of chlordecone, the thin 
eggshells and reproductive failures of birds and chronic 
toxic effects on fish served as the warning signs that led 
to restriction of the use of this chemical. 
Toxicity of Chlordecone 
Chemistry and Analytical Methods 
Chlcrooecone (Decachloro octahydro-1,3,4-metheno-2,(-
cyclobuta [cd] pentalen-2-one) is an odorless, colorless, 
crystalline solid, synthesized by derivatization of 
hexachlorocyclo-pentadiene in the presence of sulfur 
trioxide followed by hydrolysis to form a ketone (Figure 1). 
Used as an insecticide, it is added to bait and other inert 
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Figure 1 
THE STRUCTURE OF CHLORDECONE 
Cl 
Cl 
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material to control the banana root borer, tobacco wineworm, 
and domestic insect pests. It is also an ingredient in 
about 55 commercial pesticide formulas in the United States 
and other countries. It has recently come under intense 
scrutiny from a methodological and toxicological viewpoint 
because of the discovery in 1975 of environmental 
contamination by this compound near its place of manufacture 
in Virginia. 
The discovery of the persistence and widespread 
distribution of chlordecone has resulted in tremendous 
interest in the development of analytical methodology for 
the compound. Few articles on analytical methodology for 
chlordecone appear in the literature. Other articles 
pertain to 
chlordecone 
elucidation 
compounds 
Eaton et 
the evaluation of insecticidal properties of 
derivatives (Gilbert et .§!1_. I 
chlordecone 
1966) and 
or similar of the structure of 
(McBee et al., 
.§!1_., 1960). 
1956, 
Gilbert 
Griffen and Price, 1964; 
et al. (1966) prepared 
numerous alcohol and amine adducts of chlor~econt in a 
search for compounds possessing insecticidal activity. 
Brewerton and Slade (1964) presented a procedure for the 
analysis of chlordecone residues on apples, utilizing ga£ 
chromatography with electron capture (GC-EC). They reported 
0.2 nanograms (ng) as being readily detected and measured; 
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however, most of the chlordecone levels reported in other 
papers have been in the parts per million (ppm) range 
(Moseman et~., 1977). Determination of chlordecone in 
milk from cows fed treated feed was reported to be 
quantitative at 0.005 ppm (Smith and Avant, 1967). Cleanup 
of samples with oleum and dilute base was followed by GC 
with microcoulometric detection. 
The choice of solvents is critical in the extraction, 
cleanup and analysis of chlordecone. Also, unless great 
care is taken to exclude water from solvents, 
exists in solution as a hydrate. Aliphatic 
solvents 
pesticide; 
such as hexane are 
methanol, acetone 
poor solvents 
and benzene 
the compound 
hydrocarbon 
for this 
are better 
solvents. Acetone has been reported to react with 
chlordecone under 18 hours of reflux (Hodgson et~., 1978). 
At ambient temperatures methanol apparently reacts with 
chlordecone to form the hemiketal. Combined gas 
chromatography-mass spectrometry (GC-MS) indicates that the 
hydrate and hemiketal forms revert to chlordecone in the 
injection port of a gas chromatograph at temperatures above 
180 degrees centrigrade. 
Due to the polar nature of chlordecone, it is 
difficult to remove it from substrate using nonpolar 
extraction solvents such as petroleum ether or hexane. 
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several investigators have found that the most effective 
extraction solvent systems are methanol-benzene (1:1) and 
toluene-ethyl acetate (1:3). 
Pharmacokinetics 
Absorption 
Chlordecone is readily absorbed (>90%) from the 
gastrointestinal tract. This has been established in rats 
consuming chlordecone in maternal milk (Kavlock et al., 
1980) or when given as a single dose of 40 mg/kg in corn oil 
by gastric intubation (Soine et~·, 1981). The absorbed 
chlorC::.eccnc estal:.:lishes an equi l ibr i ur:-: o: 
distribution among most tissues. The equilibrium was 
achieved within 24-48 hours following a single dose to rats 
regardless of whether chlordecone was given intravenously, 
by gastric intubation, or by intraperitoneal injection 
(Kavlock et ~·, 19 5C). A similar pattern of tissue 
distribution was found in mice fed a diet containing 40 ppm 
of chlordecone for many months (Huber, 1965). Qu2ntitative 
measureffients of chlordecone absorption through the skin or 
by inhalation have not been reported. 
Distribution 
Cohn et a 1. (1978) inspected the distribution of 
chlordecone in the tissues of factory workers. From these 
studies it was evident that there was an unusually high 
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concentration of chlordecone in blood as compared to that in 
adipose tissue, the ratio being 1:7. This ratio is similar 
to that reported by Egle et al. (1978) in rats two weeks or 
26 weeks following a single dose of chlordecone (Table I). 
The high blood to fat ratio for the distribution of 
chlordecone contrasts markedly to the partitioning of DDT 
(Morgan and Roan, 1974), polybrominated biphenyls (Landrigan 
et~., 1977), and other lipophilic environmental chemicals 
(Robinson and Hunter, 1966) which are hundreds of times less 
concentrated in blood than fat. It is generally believed 
that co~ff icient cf distribution of hydrophobic 
chemicals among tissues including blood parallels the lipid 
content of the tissues (Lindstrom et~., 1974). Hence, the 
disproportionately high concentration of chlordecone in 
blood might be explained by the fact that chlordecone 
hydrate may be more water soluble than other organochlorine 
pesticides. However, from unsuccessful attempts to detect 
unbound chlordecone in plasma, it has been concluded that 
the "free" plasrr.a chlordecone, if present at all, is less 
that 1% of the total chlordecone in blood (Soine et ~., 
1981). Therefore, it has been hypothesized that chlordecone 
may be specifically associated with plasma proteins in 
preference to blood lipids (Skalsky et~., 1979). Soine et 
.§.l. ( 19 81 ) found that when ch lordecone was incubated ¥.'i th 
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Table I 
DISTRIBUTION OF RADIOLABELED CHLORDECONE IN THE MALE RAT 
(EGLE ET AL., 1978) 
Tissue Liver Fat Cerebe 11 urn Cerebrum 
Day 1 233+15.2 134+4.0 62.8+1.6 57.5+3.6 
Day 3 198+17.9 90+12.7 55.,5+3. 4 48.2+3.2 
Day 7 180+20.2 134+17.9 48.2+2.9 43.8+1.3 
Do.y 14 128+5.S 3!,+2. (. 19.0+0.8 18.5+1.~ 
Day 28 85+8.3 13+ 1. 4 8.6+0.9 8.8+1.0 
Day 49 39+2.7 9+1.0 5.0+0.4 4.8+0.5 
Day 84 18+0.9 1.1+0.2 1.1+0.l 0.9+0.l 
Day 182 3.6+0.l 0.4+0.2 0.2+0.0 0.2+0.0 
Data represEnt the n-.ean + the standard error. 
-
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human, rat, or pig plasma, more than 75% of the chemical was 
associated with the albumin and high-density lipoprotein 
fractions, whereas these same fractions from human plasma 
contained only 24% of an endogenous, hydrophobic substance, 
namely, cholesterol. Moreover, of the total chlordecone or 
cholesterol associated with human lipoproteins, the high-
density lipoprotein fraction prepared by either 
ultracentrifugation or by heparin-manganese precipitation 
followed by agarose gel electrophoresis contained 53% of the 
chlordecone, but only 22% of the cholesterol. Whereas most 
organochlorine pesticides are associated with the lipid rich 
fractions of plasma through nonspecific, hydrophobic 
interactions (Skalsky et~., 1979), specific binding of 
chlordecone by albumin and high-density lipoproteins offers 
an attractive explanation for the enormous amounts of this 
hydrophobic che~ical in such an aqueous fluid as blood. 
A seco~d distinctive feature of chlordecone 
distribution in man (Cohn et~., 1978) and rats (Egle et 
~., 197&) is that an.ong all sampled tissues, the highest 
concentration is found not in body fat, although this might 
be expected based on the distribution of most lipophilic 
compounds, but in the liver. Rats given a single dose of 
chlordecone established within 48 hours a stable partition 
ratio of chlordecone between fat and blood of 13:1, whereas 
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the ratio of the initial concentration of chlordecone in 
liver and blood was 28:1. The fat to blood concentration 
ratio remained unchanged for 26 weeks thereafter, despite 
the fact that the concentration of chlordecone in fat 
declined by a factor of 362. In contrast, the concentration 
in liver declined less rapidly during this study (by a 
factor of only 65) so that the liver to blood concentration 
ratio rose progressively during the 26 week study to a final 
value of 119:1. This finding was confirmed in mice 
chronically fed chlordecone (Huber, 1965) and in the fetuses 
of pregnant chlordecone-treated rats (Kavlock et.§..!.., 1980). 
In both studies the highest concentration of chlordecone 
among all sampled tissues was found in the liver. There is 
no explanation for the preferential sequestration of 
chlordecone in liver. Hence, 
disproportionate accumulation 
it may be concluded that the 
of body chlordecone in the 
liver is due to binding of chlordecone by constituents of 
liver me~branes, presumably proteins or lipids (Arias et 
~ .• 1920). 
Excretion 
The major route of elimination of chlordecone is in 
the stool. This has been confirmed in humans (Cohn et~., 
1978), rats (Egle et~·, 1978), mice, and monkeys (Fariss, 
1980). Only minimal amounts of chlordecone appeared in the 
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urine of these species even when tritiated-chlordecone 
tracer studies were carried out (Egle et al., 1978) (Table 
II). An exception to this generalization may be lactating 
females. Chlordecone has been detected in samples of breast 
milk from women living in southern states of the United 
States (Smith and Avant, 1967). The environmental source of 
chlordecone in this region is presumed due to extensive use 
of mirex, 
which may 
(Carlson 
which may contain chlordecone as a contaminant or 
undergo photodegradation to form chlordecone 
et~., 1976). Chlordecone promptly (within 4 
days) ap~e~r£6 in the milk of co~s started on chlordecone-
containing diets ranging from 0.25 to 5.0 ppm (Smith and 
Avant, 1967). After 60 days, the levels of chlordecone in 
the milk of the cows on these diets rose to 20 and 320 
ng/rnl, 
levels 
respectively, and then declined to barely detectable 
after resumption of a normal diet for 83 days. It 
has been estimated that female rats may excrete as much as 
52% of an acutely administrated dose of chlordecone in milk 
durin~ the lactatior. period (Kavlock et ~·, 1980). This 
may be compared to male rats which excreted 33% of a single 
dose in stool during a similar situation (Egle et ~., 
1978). 
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Table II 
RADIOACTIVITY IN FECES AND URINE AFTER TREATMENT WITH 
RADIOLABELED CHLORDECONE, 40 MG/KG (EGLE ET AL., 1978) 
Days after 
Treatment 
1 
2 
3 
4 
5-6 
7 
8-13 
14-20 
21-28 
29-35 
36-42 
43-49 
50-56 
57-63 
64-70 
71-77 
78-84 
85-91 
92-98 
99-105 
106-112 
113-119 
120-126 
127-133 
134-140 
141-147 
148-154 
15 5-161 
162-168 
169-175 
176-182 
Cumulative Excretion 
Feces (%) 
12.7+2.8 
15.6"+2.6 
18.9"+2.5 
21.1+2.1 
27.1+2.l 
29.5+2.l 
33.1+2.1 
3 i . 6-t- 2.. c 
46.0"+l.8 
5 o. 5+"1. 7 
54.1+2.0 
57.4+2.0 
59.9+2.0 
61.9+2.0 
63.4"+2.0 
64.5+2.0 
65.5+2.0 
66.3"+2.5 
67.0+2.5 
67.5+2.4 
67.9+2.5 
68.2"+2.4 
68.5"+2.4 
68.8=-2.4 
69.0"+2.4 
69.2"+2.4 
69.4+2.4 
69.5+2.4 
69.6+2.4 
69.7+2.4 
69.8"+2.5 
Urine (%) 
0.533+0.36 
0.582"+0.36 
0.603+0.36 
0.622"+0.35 
0.667+0.36 
0.688"+0.36 
Data represent the mean + the standard error. 
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General Toxic Effects 
There are no reports of death in humans exposed to 
chlordecone. Chlordecone-poisoned workers lacked such 
constitutional symptoms as fever, chills, sweating, or 
fatigue. However, in 10 of 23 cases, there was prominent 
weight loss (as much as 60 pounds in four months) despite a 
normal diet (Cohn et £1, 1978). 
The susceptibility of laboratory animals to the 
lethal effects of a single oral dose of chlordecone is 
similar between males and females (Larson et £1., 1979; 
GainEs, 1969), b;..:"'.: varies arr.ong species. The LD Su fc:v-
rabbits (71 mg/kg) is lo~er than that for rats (126 mg/kg), 
dogs (250 mg/kg), or chicks (480 mg/kg) (Sherman and Ross, 
1961 ). All rats receiving diets of 50 ppm of chlordecone or 
more died within 6 months. Mice receiving diets containing 
80 pp~ of chlordecone or higher died within 32 days (Huber, 
1965). When given daily doses of 50, 25, or 10 mg/kg, 90% 
of the animals died within 5, 9, or 24 days, respectively 
(Huang et ~., 198 0). The acute and cumulative LD 50 for 
chlordecone in mice are in the same range. The mechanism of 
death in these studies was not ascertained. Chronic dermal 
contact with chlordecone produced minimal toxicity in rats 
(Gaines, 1969). In several studies (Curtis and Mehendale, 
1979; Cannon and Kreb, 1979) of adult rats maintained fer 
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many months on diets containing more than 10 ppm 
chlordecone, significant weight loss was noted. Depressed 
growth has been observed in pregnant rats given as little as 
2 mg/kg/day of chlordecone (Chernoff and Rogers, 1976), in 
mice fed 40 ppm (Huber, 1965), in mice treated with 10 
mg/kg/day (Ho et.§...!_., 1981), in laying hens fed 75 ppm 
(Naber and Ware, 1964), and in quail fed 300 ppm (McFarland 
and Lacy, 19 6 9 ) . "Hypermetabolism" manifested by increased 
food and oxygen consumption was reported in rats (Larson et 
al., 1979) and mice (Huang et.§...!_., 1980). 
Neuromuscular Toxicity 
The sine gua non of chlordecone intoxication is an 
irregular, nonpurposive waking tremor involving the 
extremities, head and trunk (Taylor et.§...!_., 1978). Also 
present in the chlordecone poisoned worker was opsoclonus, 
an unusual oculoreotor disorder consisting of chaotic eye 
movements causing blurred vision. In some patients who 
complained of headaches, spinal fluid pressure was elevated, 
and three 
apparently 
patients had frank 
to impaired capacity 
fluid (Sanborn Et .§1_ • I 
pseudo-tumor 
to absorb 
cerebri due 
cerebrospinal 
1979) . Neuropsychiatric 
abnormalities included irritability, memory disturbances, 
exaggerated startle response and, in one case, visual and 
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auditory hallucinations (Taylor et~., 1978). No evidence 
of dysfunction of muscle or peripheral nerves was adducted, 
and muscle biopsies of five patients were histologically 
normal. 
The prompt appearance of tremors in rats (Larson et 
al., 1979; Curtis and Mehendale, 1979; Cannon and Kimbrough, 
1979; Egle et al., 1979; Desaiah, 1981), chicks (Sherman and 
Ross, 1961), Japanese quail (McFarland and Lacy, 1969), and 
mice (Huang et~., 1980) receiving chlordecone has been 
well documented. Also, like patients, chlordecone-treated 
rats and mice exhibited hyperexcitability and an exaggerated 
startle response. These rats were especially susceptible to 
chemically invoked seizures (Huang et~., 1980). A strict 
departure from the symptoms noted with chlordecone poisoned 
workers is the observation of severe muscle weakness 
following a single dose of chlordecone to chicks (Sherman 
and Ross, 1961) or rats (Cannon and Kimbrough, 1978). 
Although muscle weakness has been ascribed to effects of 
chlor6econe as a competitive inhibitor of muscle lactate 
dehydrogenase (Hendrickson and Bowden, 1975), the myopathic 
effects of chlordecone in rats appeared to be permanent, 
increasing at a ti~e when there was both a decline in 
chlordecone levels in muscle and a disappearance of 
neurotoxic manifestations (Cannon and Kimbrough, 1978). 
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Liver Toxicity 
In most of the chlordecone-poisoned workers, the liver 
and spleen were enlarged; chemical tests of liver function, 
including clearance of sulfobromopthalein (BSP) from plasma, 
was normal; histologic examination of liver biopsies 
revealed nonspecific findings, including minimal fatty 
metamorphosis, focal proliferation of sinusoidal cells, 
hyperglycogenation of nuclei, increased residual bodies, 
branched mitochondria with paracrystalline inclusions, and 
accumulation of smooth endoplasmic reticulum (Guzelian et 
al. , 19EC). T~~ last cbservation suggests that the hepatic 
microsomal cirug metabolizing system (cytochrome P-450-
dependent monooxygenase system) was induced. In line with 
this finding, workers disrlayed an accelerated clearance of 
antipyrene from the blood as compared to normal subjects. 
Furthermore, the workers had abnormally high levels of 
glucaric acid, a substance which is reported to be a 
derivative of hepatic endoplasmic reticulum (Hunter et tl·r 
1972). However, none of the workers had elevated serurr 
garnrr,a-gl utamyl transpeptidase activity, an enzyme proposed 
as a marker for the induction of hepatic drug metabolizing 
enzymes in man (i:;hi tf ield et tl·, 1973; Rosalki et tl·, 
1971). It should be noted that these effects of chlordecone 
on hepatic fu~ctions associated with the endcplasiric 
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reticulum may reflect an adaptive response on the liver 
rather that "hepatotoxicity" per ~-
Similar to the effects of chlordecone in human liver, 
treatment of rats (Ishikawa, 1978), quail (Eroschenko, 1974; 
1980), mice (Huber, 1965), or dogs (Larson et al., 1979) 
with chlordecone increased the size of the liver relative to 
the total body weight. Also similar were 'histopatholog ic 
examinations of the livers from chlordecone-treated rats 
(Chu et~., 1980), quail (Eroschenko and Wilson, 1975), or 
mice (Hewitt et £1..., 1979) which revealed only such 
nonspecific changes as fatty infiltration, pleocytosis, and 
focal lymphoid aggregates. 
fibrosis, 
necrosis. 
cholestasis, or 
There was no evidence of 
significant he pa toce 11 ul ar 
The hepatic drug metabolizing system is induced in 
rats treated with commercially available chlordecone. 
Chlordecone treatment increased the concentration of the 
drug binding hemoprotein, microsomal cytochrome P-450, the 
level of NADPH-cytochrome C reductase activity, and the 
activity of cytochrome P-450 dependent oxidation of 
pentobarbital (Mehendale et~., 1977; 1978). Pentobarbital 
sleeping time was reduced by chlordecone pretreatment of 
rats (Mehendale .§.! ~·, 1978). It has been concluded that 
chlordecone resembles the prototype inducer, pentobarbital, 
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because of the profile of its effects on the hepatic 
microsomal monooxygenases, and because chlordecone binds to 
cytochrome P-450 (Ebel, 1980). However, it should be noted 
that commercially available chlordecone contains an impurity 
that is reported to be solely responsible for the 
"phenobarbital-like" induction in aryl hydrocarbon 
hydroxylase activity in genetically responsive mice (Nebert 
et ~. , 19 77). To resolve the question of induction of 
cytochrome P-450 by chlordecone, Guzelian (1980) 
administered a single oral dose of highly purified 
chlordecc~c (>99.9~, bas£~ on GC-MS) to male rats (40 me/kc: 
_, -
or gerbils (20 mg/kg) and found the concentration of hepatic 
microsomal cytochrome P-450 increased an average of 150% and 
259%, respectively. 
Toxic Effects In The Endocrine And Reproductive Systems 
There were no overt clinical manifestations of 
endocrinologic toxicity among 28 of the chlordecone poisoned 
male worktrs except for complaints of decreased libidc in 
seven patients. All of the patients had normal serum levels 
of follicle stimulating hormone, luteinizing hormone, and 
testosterone (Anderson et al., 1976). Nevertheless, only 
eight patients had normal sperm count, and in only one of 
these eight was the concentration of chlordecone in blood 
greater than 1000 ng/ml (Cohn et~., 
low or absent sperm numbers were 
abnormally low percentage of motile 
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1978). In all cases, 
associated with an 
sperm. Histologic 
examinations of testicular biopsies in two patients revealed 
arrest of sperm maturation (Anderson et al., 1976), a 
finding that suggests a potentially reversible lesion. In 
12 of 13 cases where it was possible to make repeated 
examinations of sperm in a given individual over several 
years, there was an increase in the concentration of motile 
sperm coinciding with a fall in blood levels of chlordecone 
(Cohn et£..!_., 1978). Several years have elapsed since the 
chlordecone was removed from the body tissues of these men. 
Although no comprehensive study of reproductive function has 
been carried out, several individuals have since fathered 
children. No information is available regarding the effects 
of chlordecone on reproductive function in women. 
Blocked or impaired reproductive function in 
chlordecone-treated birds and rodents has been abundantly 
documentea. Chronic consumption of diets containing eve~ 
small amounts of chloraecone by bobwhite quail (1 to 25 ppm) 
(Dewitt et~., 1962), by pheasants (5 to 10 ppm), by laying 
hens, or by Japanese quail (200 ppm) (Eroschenko, 1977; 
1978; 1979) reduced the number of eggs produced. Morever, 
these eggs were smaller than normal, had reduced eggshell 
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thickness and strength, hatched less frequently, and 
produced defective chicks with decreased survival rates 
(Eroschenko, 1977; 1978). Similarly, feeding chlordecone to 
inbred mice (5 or 10 ppm) (Good et~., 1965) or rats (25 
ppm) (Cannon and Kimbrough, 1979) reduced the number and 
size of the litters produced. The defect was primarily 
associated with females and could be reversed within several 
months upon resumption of a normal diet (Mehendale, 1977). 
Overt teratogenic effects are observed at higher doses of 
chlordecone. An increased number of offspring exhibited a 
variety of toxic manifestations such as low fetal weight and 
reduced postpartum survival (Chernoff et al., 1979). 
Chernoff and Rogers (1976) observed developmental 
abnormalities involving the skeletal, ureterogenital, and 
central nervous syste~. In multigenerational studies, 
decreased reproductive capacity was seen in adults (Good et 
~., 1965). 
The consensus vie~ of all these investigators is that 
chlordecone imp~irs reproduction by mimicking the effects cf 
excessive estrogens. For example, testicular atrophy was 
reported in chlordecone-treated rats (Larson et ~., 1979) 
and quail (Eroschenkc and Wilson, 1974). Gross and 
histologic examinations of testes taken from chlordecone-
treated quail (McFarland and Lacy, 1969) showed a congeries 
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of findings (reduced size, decreased spermatogenesis, and 
abnormalities of the seminiferous tubules) similar to those 
produced by estrogen administration to birds. Chlordecone 
treatment also produces a variety of "estrogen-like" effects 
on the female reproductive system. In immature quail or 
chicks, chlordecone treatment caused premature development 
of the oviduct, manifested grossly by an increase in oviduct 
weight, and histologically by the presence of cilia, 
cellular proliferation and differentiation, formation of 
tubular glands, and secretory activity. Examination of the 
treated quail ovaries revealed fewer eggs and impaired 
follicular development (.McFarland and Lacy, 1969). In 
immature rats, chlordecone produced an increase in uterine 
gro~th, a persistent vaginal estrous, anovulation, and the 
disappearance of corpus lutea from the ovaries (Gellert, 
1978). The ultramicroscopic changes in the cell lining of 
the oviduct, vagina, and uterus of these rats was 
characteristic of those produced by estrogenic steroid 
horrr.cnes. 
It has been suggested that the estrogenic effects of 
chlordecone may be exerted indirectly through the 
hypothalamic pituitary system by prolonging release cf 
follicle stimulating hcrmcne and preventing release of 
luteinizing hormone (Huber, 1965). However, it should be 
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noted that these studies were carried out prior to the 
advent of sensitive and specific immunochemical techniques 
for measuring pituitary hormones. There is now strong 
evidence that chlordecone exerts its estrogenic effects 
directly. When incubated with explants of chick oviduct in 
vitro, chlordecone, like estradiol, induced de novo 
synthesis of specific egg white proteins and increased the 
number of specific mRNA sequences encoding for these 
proteins (Palmiter and Mulvihill, 1978). These effects 
could be prevented by tamoxifen, an antiestrogen that 
competitively inhibits binding of estradiol to its specific 
cytoplasmic receptors (Palmiter and Mulvihill, 1978). 
Moreover, there was competition between estrogen and several 
preparations of highly purified chlordecone for binding to 
nuclear (Hammond et~., 1979) and cytoplasmic (Bulger et 
~., 1979) estradiol receptors. Chlordecone stimulated 
transfer of the cytoplasmic estradiol receptor into the 
nucleus and stimulated synthesis of the progesterone 
receptor ( Hammor,d et a i. , 19 79). These are two process es 
for which the estrogen receptor is thought to be 
indispensible. Despite the fact that chlordecone was found 
to be 10,000 times weaker than estradiol in its biological 
effects or in its affinity for the estrogen receptor 
(Palmiter, 1978), it is possible that persisting in.tissues 
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in high concentrations, chlordecone may produce local 
adverse estrogenic effects on the reproductive system 
(Hammond et~., 1979). This hypothesis would account for 
the selectivity and reversibility of estrogen-like effects 
of chlordecone on the testes of the poisoned workers. 
Neurotoxicity 
The mechanism of chlordecorie neurotoxicity has been 
attributed to inhibition of mitochondrial and synaptosomal 
membrane bound sodium-, potassium- ATPase(s). Research 
groups at the University of Mississippi have worked 
sedulously tc docu~e~t this property of chlordecone usin~ 
various tissue sources for the enzyme. These include brain 
from untreated or chlordecone-treated rats (Desaiah, 1981; 
Mishra et al., 1980; Desaiah et~., 1980a), mice (Ho et 
~., 1981; Desaiah et~., 1980b), and catfish (Desaiah and 
Koch 1975); muscle from the heart (Desaiah, 1981) or 
extremeties (Mishra et al. , 19 80) in rodents; 1 i ver from 
chlordecone-treated rats (Curtis and Mehendale, 1979); or 
isolated perfused rat liver preparations (Desaiah et .9...1·, 
19 77; Mehenda 1 e, 19 7 7) . 'I'he extent of the inhibition of 
sodium-, potassiurn-ATPase and oligomycin-sensitive magnesium 
ATPase activities in brain synaptosomes prepared from 
chlordecone-treated rodents was directly proportional to the 
concentration of cblordecone in the brain (Ho et~., 1981) 
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and was proportional also to the degree of tremor produced 
in the animal. Furthermore, several investigators (Desaiah, 
1981; Mishra et~., 1980) have demonstrated inhibition of 
this enzyme activity in vitro was blocked in a dose-
dependent fashion by chlordecone. Added chlordecone 
produced a greater inhibition of the enzyme than did an 
equal amount of mirex, a compound that produces no tremors 
in vivo (Desaiah et~., 1980b), and yet is structurally 
similar to chlordecone. Finally, the inhibition of ATPase 
activity can be reversed if bound chlordecone is removed by 
washing (Desaiah, 1981) or by addition of anti-chlordecone 
antibodies (Mishra et~-, 1980). The Mississippi research 
group believes that neurotoxicity may be due to an 
inhibition of synaptosomal membrane ATPase(s) by 
chlordecone, resulting in blocked cellular uptake and 
storage of such neurotransmitters as catecholamines 
(Desaiah, 1980). Others have suggested that chlordecone 
inhibits a step in rat brain mitochondrial energy production 
prior to the magnesium ATPase reaction (End et~., 1979). 
This results in loss of the capacity of mitochondria to 
maintain normal rates of calcium ion uptake, leading to an 
increase in cytoplasmic calcium ion. 
neuronal membrane would ensue, 
Depolarization of the 
promoting release of 
neurotransmitters (Carmines et~., 1979). Since the toxic 
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manifestations of chlordecone bear little resemblance to 
those of cyanide, a classical mitochondrial poison, 
nonspecific loss of cellular energy seems an unconvincing 
explanation for chlordecone toxicity. On the other hand, 
competitive, reversible inhibition of ATPase linked 
processes by chlordecone could explain (a)· the reversibility 
of neurotoxicity associated with decreasing concentrations 
of chlordecone in human tissues (Cohn et al., 1978; Taylor 
et ~. , 19 7 8) ; ( b) the inhibition of cerebrospina 1 f 1 uid 
uptake in humans which is thought to be dependent upon 
socium, potassiur:-: ATP2se (Sanborn et~., 1979); and (c) the 
decrease in brain content of neurotransmitters in 
experimental animals treated with chlordecone (Ho et ~., 
1981). 
Chang-Tsui and Ho (1980) suggested that one of the 
actions of chloroecone in the CNS is on neurctransmitter and 
receptor interaction. Decreases in tritiated spiroperidol 
binding to striatal preparations were observed in rats fee 
as little as 10 ppm chlordecone (Seth et al., 1981). In the 
same studies higher doses depressed tritiated muscimol and 
tritiated quiniclidinyl benzilate binding in cerebellum. 
Binding affinities returned to 
following cessation of treatment. 
chlordecone perinatally and then 
normal within 30 days 
Rats exposed to 6 ppm 
subjected to f cotshock 
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stress at 80 days of age were found to have reduced dopamine 
(DA) levels in the caudate nucleus; however, no evidence of 
altered DA turnover was observed in associated measurements 
of DOPAC levels (Rosecrans et al., 1982). The same studies 
found increases in serotonin turnover in all brain regions 
examined. 
Therefore, several investigators have demonstrated 
that chronic exposure of adults to chlordecone produced 
pronounced, but apparently reversible, effects on membrane 
protein content and transmitter-receptor sites in several 
brain regions. Chang-Ts~i and Ho (1980) disco~ered that 
gestational and lactational dosing with this agent caused 
decreased dopamine receptor binding intensity that was 
detected 18 days after cessation of maternal dosing. These 
changes were in the opposite direction to those caused by 
dosing of adult rats. A tendency of a toxic agent to cause 
opposite receptor changes in the brain of gestationally or 
neonatally exposed anireals relative to adult exposure has 
also been observed in the case of acrylamide (Agrawal and 
Squibb, 1980). These data confirm the general concept of 
the distinctive susceptibility of young animals to toxicants 
and the possible tendency for early toxic insult to be less 
reversible than the corresponding phenomenon in the adult. 
The sensitivity of the immature brain to environmental 
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agents acting over a long period of time may be greater than 
its susceptibility to acute damage by stroke or other anoxic 
episodes. 
Carcinogenicity 
The National Cancer Institute sponsored a 
carcinogenesis bioassay of technical grade chlordecone (>98% 
purity) in Osborne-Mendel rats and B6C3Fl mice (National 
Cancer Institute, 1976). The initial doses were found to be 
too high and had to be reduced during the study because of 
excessive mortality. The four groups of animals, male rats, 
female rats, male mice and female mice, ultimately received 
a "low" (8, 18, 20 or 20 ppm, respectively) dose or "high" 
(24, 26, 23 or 40 ppm, respectively) dose for 80 weeks. 
This was followed by resumption of a normal diet for either 
32 weeks (rats) or 10 weeks (mice). There were no 
hepatocellular carcinomas in control rats, whereas the 
incidences in hish dose rats were 7% for males and 22% for 
females, both significantly increased. The incidences of 
hepatocellclar carcinomas in female mice receiving the low 
dose (52%) or high dose (47%) groups were significantly 
higher than in controls (0 of 40 mice). Male mice receiving 
the low dose (81%) or high dose (88%) had a significantly 
higher incidence of liver tumors as compared to matched 
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controls (32%). Moreover, the time to detection of the 
first hepatocellular carcinoma was significantly shortened 
in all groups of treated mice. Metastases of the 
hepatocellular carcinomas were not observed, and there were 
no significant increases in extrahepatic tumors. From these 
studies it was concluded that chlordecone was a liver 
carcinogen in 
reinterpreting 
bioassay and 
rats and mice. Reuber (1978; 1979), 
the histologic material available from 
from studies of rats fed 1 ppm or 5-25 
in 
this 
ppm 
(Larson et~., 1979) of chlordecone for 12-24 months, had 
reached the same conclusions. In addition to carcinomas, 
other investigators (Cueto et £..!., 1978; Reuber, 1978) 
observed hepatocellular noncancerous proliferative lesions 
accompanied by fatty infiltration and degeneration. 
The mechanism underlying production of liver cancer by 
chlordecone is unknown. Although most agents that are 
carcinogenic in rodents also produce mutations in short term 
tests in animals or ir, vitro, chlordecone, like some other 
organochlorine insecticides, proved to be negative wheL 
rnutagenicity was assayed using the Ames test (Schoeny et 
5.1_. ' 1979). Chlordecone also proved to be negative as a 
tested for enhancement of unscheduled DKA mutagen when 
synthesis 
(Williams, 
in priffiary cultures of adult rat hepatocytes 
1980; Probst et .§!1., 1981). It has been 
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suggested that chlordecone is a promoter. "Promotion" 
relates to a current concept of experimental liver 
carcinogenesis which involves a multistage process. First, 
preneoplastic hepatocytes are formed by exposure of the 
liver to a "true" or complete carcinogen ("initiator"). 
However, these cells may remain dormant unless the liver is 
exposed to a second agent which, while not necessarily 
carcinogenic by itself, enhances development of the 
preneoplastic cells into malignancies ("promotion") (Pitot 
and Sirica, 1980; Farber, 1980). 
The determination of the molecular and biochemical 
mechanisms underlying the responses of the nervous system to 
toxic insults remains a complex and difficult task. 
However, recent advances in neurochemistry have provided 
suffici8nt knowledge to suspect that compounds that 
interfere with such processes as energy metabolism, 
axoplasmic transport, protein synthesis, and chemicaJ 
neurotrans~ission may be neurotoxic. Furthermore, the 
availability of new methodology permits analysis of 
specific, dynamic neurochemical events. These developments 
can provide productive, interpretable, and diverse 
approaches for evaluating the effects of toxic agents on 
nervous syster.. functioning. 
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Receptors 
Receptor Bin~ing 
An important approach developed in recent years is the 
study of membrane receptors that specifically bind 
neurotransmitters. These reversible, high-affinity 
interactions are stereospecific and nonenzymatic, have 
equilibria with very low dissociation constants, and involve 
configurational recognition (Heilbronn and Bartfai, 1978; 
Yamamura et~., 1981). Such binding is the first step by 
which the presynaptic neuron causes ionic and biochemical 
changes in the cell containing the receptor. Kinetic 
characteristics of binding of receptor density are measured 
by incubation of membranes with radioactively labeled 
compounds that bind specifically to receptor sites. Excess 
ligand unbound to the membranes is removed by filtrational 
means. Nonspecific binding of the labeled compound is 
estimated by repeating the incubation in the presence of a 
relatively high concentration of the unlabele~ 
pharmacological agent or neurotransmitter. In general, the 
pharmacological most potent binding ligands are the 
antagonists or agonists of a given neurotransmitter, rather 
than the transn,itter itself. 
be more sensitive than 
Receptor binding studies may 
assays of gross levels of a 
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neurotransmitter. For example, the neuroleptic drug 
chlorpromazine does not alter brain dopamine levels, but has 
major effects on dopamine binding sites and on the turnover 
rate of dopamine (Creese et al., 1978). This approach has 
led recently to several important findings in neurobiology 
and neuropharmacology. Among these are the discovery of 
endogenous brain analgesic and anxiolytic compounds, a 
better understanding of the mechanism of action of the major 
tranquilizers 
the relation 
and anticonvulsants, and advances concerning 
of chemistry to many neurological and 
psychiatric diseases (Snyder, 1979). Since the discovery 
that antischizophrenic drugs bind to dopamine receptors and 
that the degree of binding was related to the potency of the 
drug, receptor binding assays have been used as a quick 
screen for testing drugs. 
Receptor density is a dynamic phenomenon subject to 
relatively rapid changes. There is often an inverse 
relation between extracellular level of a ligand and the 
density of its corresponding receptors on the surface o! the 
cell (Minnernan et ~-, 
their own activity 
1979). Thus, receptors may regulate 
by increasing or decreasing their 
concentration or their sensitivity to the neurotransmitter. 
Such regulation may serve as a homeostatic mechanism whict 
ensures appropriate physiological responses in the recipient 
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cell. However, in a variety of disease states, this 
compensatory mechanism can act against the interests of the 
organism. It can also frustrate pharmacological efforts to 
enhance or suppress a given neurotransmitter system, and may 
account for the development of drug tolerance and 
habituation (Russel et al., 1975). Malfunctioning of 
receptors (either by decreased sensitivity or enhanced 
sensitivity) have been implicated in a variety of 
neurological and behavioral disorders. These include such 
clinical manifestations as schizophrenia, myasthenia gravis, 
Parkinson's and Huntington's diseases, terminal shock, 
epilepsy, and asthma (Melnechuk, 1978). Receptor changes 
have also been noted during normal aging (Makrnan et ~., 
1979) and after exposure to alcohol (Michaelis et ~., 
1978). 
Recent evidence indicates that some 
substances may affect neurotransmitter receptor 
In vivo and in vitro studies have shown 
concentrations o::: cacimi ur;; inhibit stria ta 1 
neurotoxic 
modulaticn. 
that 1 ov.-
rr.uscar inic 
acetylcholine receptors (Healund et~., 1979). Other heavy 
~etals, such as lead and mercury, have also been shown to 
inhibit a variety of putative neurotransmitter receptor 
sites by binding to the receptor site (Bondy an6 Agra~al, 
198C:). Acrylamide treatment has been shown to incre_ase the 
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affinity 
(Agrawal 
of striatal spiroperidol binding in adult rats 
et~., 1981). Therefore, determination of the 
number of receptors, such as central muscarinic receptors, 
can provide a valuable tool in evaluating the neurochernical 
response to toxic agents. 
Muscarinic Receptors 
Muscarinic acetylcholine receptors (mAchR) are present 
in neurons in both the peripheral and central nervous 
system, in many exocrine glands, and in both cardiac and 
smooth muscle. Electrophysiological and pharmacological 
tech~iques have been used to study the role and action of 
mAChRs in mediating cholinergic synaptic transmission. 
These investigations have shown that mAChRs in different 
tissues may act in different ways. For example, activation 
of mAChRs causes depolarization by increasing membrane input 
resistance in cortical neurons, sympathetic neurons and 
hippocarnpal neurons, and causes hyperpolarization of cardiac 
pacemaker and atrial cells by increasing potassium 
permeability (Hartzell, 1981). The relatively recent 
development 
affinity 
facilitated 
of radiolabeled ligands which bind with high 
and specificity to the mAChR have greatly 
molecular studies of the mAChR. Such ligands 
have permitted studies on the localization of the receptor 
(Table III), detailed analysis of the interaction of the 
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Table III 
REGIONAL DISTRIBUTION (IN VITRO) AND ACCUMULATION (IN VIVO) 
OF TRITIATED QNB IN RAT BRAIN (SNYDER ET AL., 1975) 
Brain Regions 
Corpus striatum 
Cerebral cortex 
Hippocampus 
Superior and 
inferior 
coll iculi 
Midbrain and pons 
Thalamus 
Hypothalamus 
Medulla 
oblongata-
cervical spinal 
cord 
Cerebellar cortex 
Distribution Accumulation 
478+82 426 
390+23 3 48 
243+11 278 
230+83 
150+61 
137+35 
131+38 59 
51+5 15 
3 4+ 3 0 
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receptor with agonists and antagonists, and investigation of 
mechanisms of regulation of receptor number. 
The regulation by synaptic activity of the 
macromolecules important for neural transmission represents 
a mechanism for the modulation of the activity and function 
of nerve cells. For example, prolonged exposure of 
receptors to a neurotransmitter can lead to a decrease in 
the number of receptors remaining on the cell surf ace and 
thus decrease the sensitivity of the cell to further 
stimulation. Such agonist-induced decreases ('down-
regulation') in receptor nu~Ler have been postulated to be a 
mechanism for the regulation of postsynaptic sensitivity by 
the overall level of synaptic activity. The mAChR is an 
example of a receptor whose number can be changed by 
exposure to receptor agonists. Thus, decreases in the 
number of mAChRs have been demonstrated after prolonged 
agonist exposure in cell cultures of neural lines (Klein et 
~., 1979), neurons (Siman and Klein, 1979), and cardiac 
muscle (Galper and Smith, 1978). These effects can be 
blocked by receptor antagonists; simple occupancy of the 
receptor by a physiologically inactive ligand is not 
sufficient to induce receptor loss. The kinetics of 
receptor loss suggest that it is due to an increase in the 
rate of receptor breakdown, ~ith the half-life for turnover 
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of the receptor decreasing from 11 hours to 3 hours (Lanier 
et ~., 1976). After cessation of agonist-receptor 
interaction, a gradual recovery of receptor number occurs 
which can be blocked by inhibition of protein synthesis. 
The loss of receptors is presumably mediated by an agonist-
induced endocytosis process similar to those that are known 
to regulate other membrane proteins. 
Studies with cultured cells have demonstrated that the 
loss of receptors from the cell surface is accompanied by a 
reduction in the physiological responsiveness to further 
cholinergic stimulation. 
agonist-induced decreases 
decrease in the number of 
In cultured neuronal cells, 
in receptor number lead to a 
mAChR-mediated inhibition of 
adenylate cyclase (Nathanson et tl·, 1978) and the mAChR-
mediated turnover of membrane phospholipids, while in 
cultured cardiac muscle a decrease in the number of mAChRs 
leads to a decreased negative chronotropic 
further muscarinic stimulation (Galper and 
response tc 
Smith, 19 7 E ) • 
These changes i~ receptor number and responsiveness occur or. 
a time scale for hours. Thus, they are distinguished fro~ 
the short-terrr desensitization of receptor function, which 
both occurs and can be reversed on a time scale of minutes, 
and is not accompanied by a significant decrease in apparent 
receptor number (Taylor et ~· , 19 79). 
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Muscarinic receptor number in vivo can be altered by a 
variety of pharmacological treatments. Chronic 
administration of acetylcholinesterase inhibitors leads to a 
decrease in the number of mAChRs present in the brain, 
presumably because the acetylcholinesterase increases the 
concentration of endogenous acetylcholine available for 
receptor binding (Smit et 5!.!.·, 1980). Conversely, prolonged 
treatment of brain tissue with specific mAChR antagonists 
results in increased rnAChR number, presumably because 
synaptic release of acetylcholine is prevented f rorn 
interacting with the mAChR (Ben-Barak and Dudai, 1980). In 
vivo administration of cholinergic agonists can directly 
regulate the number and function of mAChRs in heart 
(Halvorsen and Nathanson, 1981) and brain (Meyer et al., 
1982) with characteristics strikingly similar to those of 
the regulation seen in cell culture. The number of mAChRs 
in the heart can be reduced by more than 85%; receptor 
number gradually returns to control levels if subsequent 
agonist-receptor interactions are blocked by thE: 
adffiinistration of an antagonist. The decrease in receptor 
number is correlated with a decrease in negative 
chronotropic (affectino the rate of contraction) response of 
isolated atria to muscarinic stimulation. These experiments 
also demonstrated that desensitization and down-regulation 
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are distinct processes; the negative chronotropic response 
of the atria desensitized within a minute after exposure to 
the agonist, while the decrease in receptor number required 
6-10 hours to reach a steady state (Nathanson, 1982). 
Inositol Phospholipids 
Phospholipids in Developing Brain 
During the first few weeks of life the brain of the 
rat undergoes a period of rapid growth and differentiation. 
Three stages of development may be distinguished: (1) The 
period from birth to 15 days is characterized principally by 
growth of unmyelinated axon processes and glial cells, 
resulting in a five-fold increase in brain mass. (2) At 
about the 10th day the deposition of myelin is initiated and 
achieves maximal rates in the next 10 days. Cell division 
and cell growth level off during this period. (3) 
Subsequently there is a slower continued formation of 
myelin. The adult levels of most components are reachec by 
the third month (Nchurray, 1964; Folch, 1955). 
Studies of the lipid composition of the developing 
brain have shown that the lipids increasing in association 
with the early gro~t~ phase are the mucolipids (Felch, 1955) 
and many of the glycerophosphatides. Lipids typically 
associated with the later myelination period include 
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cholesterol, sphingomyelin, cerebrosides and plasmalogens 
(Folch, 1955; McMurray, 1964). 
Distribution 
Phosphatidylinositol (PI) is a minor membrane 
component constituting about 10% of the phospholipid content 
of most eucaryotic cells (Michell, 1975; Hawthorne and Kai, 
1970; Becker and Lester, 1977) (Table IV). It is a 
precursor for the phosphoinositides, phosphatidylinositol 4-
phosphate (DPI) and phosphatidylinositol 4,5-bisphosphate 
(TPI), which are unique phospholipids because they possess 
additional phosphate sroups ffionoesterified to the inositol 
ring (Figure 
phospholipids. 
2). They are the most polar of all the 
The polyphosphoinositide (PPI) levels, 
localization, and metabolism have been studied in a variety 
of tissues for the past 30 years. The greatest 
concentration of polyphosphoinositides occurs in the nervo~s 
system. A substantial body of evidence now indicates that a 
large proportio~ of the polyphosphoinositides, especially 
TPI, are localized in the rnyelin sheath that surrounds the 
nerve fibers. The relative concentrations of the individual 
polyphosphoinositides will be dependent on factors such as 
age. Brain homogenates from developing rats, when incubated 
With the appropriate precursor, display marked differences 
in their ability to synthesize DPI and TPI as a function of 
Table IV 
PHOSPHOLIPID COMPOSITION OF SYNAPTOSOMAL MEMBRANES 
FROM RAT BRAIN (HOFTEIG ET AL., 1985) 
Synaptosomal Plasma Membrane (Percent of total) 
Phosphatidylcholine (PC) 
Phosphatidylethanolamine (PE) 
Phosphatidylinositol (PI) 
Phosphatidylserine (PS) 
Phosphatic acid (PA) 
Phosphatidylglycerol (PG) 
Lysophosphatidylcholine + 
Sphingomyelin (LPC + SP) 
42.6+4.6 
20.5+12.l 
10.8+0.8 
14.2+2.8 
1.5+1.2 
1.8+0.l 
3.6+1.3 
Values represent the mean + the standard error. 
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Figure 2 
THE COMMON PHOSPHATIDYLINOSITOLS 
PHOSPHATIDYLINOSITOL 
0 
I 1,2-DIACYLGLYCEROL-O-r-o~ 
DIPHOSPHATIDYLINOSITOL 
TRIPHOSPHATIDYLINOSITOL 
0 
I ~ o*° 1,2-DIACYLGLYCEROL-o-y-o~: 
0 OJ(O 
0 
51 
age (Figure 3). The formation of DPI, expressed per 
milligram protein, was greatest at the youngest age 
examined and fell during development, so that the level in 
the adult was about one-third that in the newborn rat. By 
contrast, while substantial amounts of TPI were synthesized 
by homogenates from 2-day-old rats, the quantity formed was 
twice as high by the third week and five times as high in 
the mature animal (Eichberg and Hauser, 1967). 
Until recently, quantitative separation of of TPI and 
DPI from PI presented a number of difficulties so that most 
publisheo st2tements about their concentrations could only 
be regarded as minimu~ figures (Table V). The most reliable 
figures are probably derived from brains fixed by microwave 
irradiation (Soukup et~·, 1978), where values for three 
brain regions are 0.1-0.13 umol DPI and 0.29-0.48 umol TPI 
per gram tissue. Of this, about one half is found in the 
myelin fractions that contain only about one quarter of the 
total lipid of the homogenate (Deshmukh ~! ~., 1980). This 
puts the concentration of PPI in the myelin in situ at a 
minimum of 1 m~i. The local concentration at the cytoplasmic 
leaf let of the membrane is almost certainly higher than 
this. Another estimate of local concentration has been 
obtained from human erythrocytes, where TPI and DPI 
constitute about l~ of the total phospholipids. Assuming 
12 
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Figure 3 
EFFECT OF AGE ON THE BIOSYNTHESIS OF BRAIN 
POLYPHOSPHOINOSITIDES (EICHBERG AND HAUSER, 1967) 
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Table V 
PHOSPHOINOSITIDE CONTENT OF BRAIN TISSUE 
(EICHBERG AND HAUSER, 1967) 
Source 
Sheep brain 
Rabbit brain 
Ether extract 
of rat brain 
Ox brain 
diphosphoinositide 
fraction after 
ten precipitations 
(purified) 
Phospholipid 
Phosphatidylinositol 
Phosphatidylinositol 
Diphosphatidylinositol 
Triphosphatidylinositol 
Phosphatidylinositol 
Diphosphatidylinositol 
Triphosphatidylinositol 
Phosphatidylinositol 
Diphosphatidylinositol 
Triphosphatidylinositol 
Phosphatidylserine 
P as % total 
lipid p 
3.2 
1.83 
0.87 
4.29 
2.60 
0.42 
0.47 
7.0 
39.4 
37.4 
16.3 
These figures are expressed as percentage by weight of the 
total solids extracted. 
that phospholipids provide 25% of the mass of the 
erythrocyte membrane and that all of the PPis are 
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hydrated 
in the 
cytoplasmic leaflet of the membrane (Garrett and Redman, 
1975), the total concentration of TPI and DPI at the surface 
is on the order of 5 mJ\i (Sheetz et g., 1982). 
Several investigators have proven that DPI and TPI are 
characteristic constituents of the plasma membrane (Michell, 
1975; 1979; Hawthorne and White, 1975; Agranoff, 1978). 
This proof is largely based on the presence of PPI in myelin 
and erythrocyte membranes, and on the fact that PPI kinase 
is concentrate~ in plasrra membranes of liver and some other 
tissue. There seems to be a general relationship between a 
tissue's PPI content and the richness of its plasma membrane 
complement, e.g., these lipids are present in high 
concentrations in myelin-rich nervous tissue and in kidney. 
At the other extreme would come a tissue such as liver which 
has large cells and hence has little of its mass contributed 
by plasma membrane: liver contains little PPI (Sheetz et 
~., 1982; Michell et~., 1970). The best, but still 
approximate, estimate of PPI level in rat liver comes fro~ 
the measurements of acid-extractable inositol lipid and of 
DPI and TPI made by r.;ichell et al. (1970). These suggest a 
total concentration for the two lipids of 20-40 nmol/g 
tissue. If PPI were to be confined to the inward~facing 
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half of the hepatocyte plasma membrane, which probably 
accounts for less than 1% of the mass of the tissue, they 
would have found there a local concentration of 2 mM. 
Thus, DP! and TPI are minor, indeed trace, lipid 
components when considered either by comparison with the 
major membrane phospholipids or simply as components of an 
entire eucaryotic cell, but this type of interpretation may 
conceal the fact that they are present at quite high local 
concentrations at the inner surface of the plasma membrane, 
and perhaps in related membranes such as secretory vesicles. 
Biosynthesis and Degradation 
There is no single cell in which all of the known 
steps in the metabolic pathways to and from DPI and TPI have 
been fully characterized, so the widely accepted set of 
metabolic pathways, shown in Figure 4, is based on an 
asserrblage of information from many cells. It is generally 
agreed that most synthesis of PI from phosphatidate (PA) 
(reaction 1 and 2) occurs at the endoplasmic reticulum. 
Synthesis of DPI by PI kinase (reaction 3) is a widespread 
activity in plasma membranes (liver, erythrocytes, brain, 
and kidney) (Hawthorne and White, 1975) but has also been 
reported in a soluble fraction from brain, in adrenal 
rnedullary secretcry vesicles, and in 'microsomal' fractions 
from liver and kidney. This 'microsomal' activity, which 
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Figure 4 
PATHWAYS FOR THE SYNTHESIS AND DEGRADATION OF 
INOSITOL PHOSPHOLIPIDS (HAWTHORNE AND WHITE, 1975) 
ATP ADP 
PI 
(3) \..._ 
.1' ~ DPI 
.c ( 6 ) 
Pi 
( 8 ) 
Phosphatidyl-CMP 
PPi~ ( 1 ) 
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::11.· TPI 
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CTP1 Ar _;w~ J-/ 
Phosphatidate/. ~ 1,2-diacylglycerol T ~i 7 i 
\I 
Synthesis de nova (may come from other lipids) 
Enzymes in pathways: 
(1) ER kinase 
(2) ER kinase 
(3) PI kinase 
(4) DPI kinase 
{ 5) PPI phosphon:onoesterase 
(6) TPI phosphomonoesterase 
(7) TPI phcsphodiesterase 
(8) PPI phosphodiesterase 
(9) PPI phosphodiesterase 
p 
Pi 
Pi 
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shows characteristics different from those in plasma 
membrane-enriched fractions, was ascribed by Harwood and 
Hawthorne (1969) to a PI kinase of the endoplasmic 
reticulum. However, both hepatocytes and kidney tubular 
epithelium have plasma membranes that are differentiated 
into biochemically distinct domains, some of which co-
sediment with endoplasmic reticulum fragments in 
'microsomal' fractions. Synthesis of TPI from DPI (reaction 
4) is catalyzed by a second kinase. In the erythrocyte and 
kidney this activity is associated with the plasma me~brane 
(Hawthorne and Pickard, 1979), but in brain it appears 
principally in the soluble fraction (Hawthorne and Kai, 
1970). The subcellular distribution of PI kinase and DPI 
kinase 
determine 
are particularly important because they 
at which intracellular membrane sites 
will 
PPI 
synthesized from PI will accumulate. Of these two enzyme 
activities perhaps PI kinase may be more strictly localized, 
since the subsequent activity of DPI kinase will be limited 
by the availability of its substrate. 
Dephosphorylation of TPI (reaction 5) and of DPI to PI 
(reaction 6) were first achieved using crude extracts of 
brain and liver (Hawthorne, 1964; Ha~thorne and White, 
1975). PPI phosphomonoesterase activity initially appeared 
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to be largely soluble in the brain, but Sheltawy and Dawson 
(1969) later discovered a membrane-bound activity that 
required a component of the soluble phase as an activator. 
Comparisons with marker enzymes suggested that the membrane-
bound activity was at the plasma membrane (Hawthorne and 
White, 1975). Studies of kidney pointed at first to a PPI 
phosphomonoesterase activity in the cytosol and the 
endoplasmic reticulum (Lee and Huggins, 1968) that could not 
be attributed to alkaline phosphatase. But more detailed 
studies using 'improved' assays then revealed a substantial 
amount of P~l phospho~onoesterase activity that seemed to be 
associated with Gol9i membrane (Cooper and Hawthorne, 1975). 
The fact that it co-purified with thiamine pyrophosphate and 
not galactosyltransferase may indicate that it is in the 
trans elements of the Golgi complex (Rothman, 1981). 
From the studies just described, it appeared that one 
phosphomonoesterase might dephosphorylate both DPI and TFI 
(Cooper and Hawthorne, 1975). However, this seerr,s 
intrinsicc.lly ur:likely, given 
environments of the 5-phosphate 
the different 
of TPI and of 
physical 
the 4-
phosphate of DPI; furthermore, a recent study of a soluble 
activity in erythrocytes by Roach and Palmer (1981) has 
yielded a specific TPI phosphomonoesterase that removes only 
the 5-phosphate and is inactive against DPI. 
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The other major route of breakdown of PPI is by the 
action of phosphodiesterase(s) (i.e. phospholipase(s) C) 
that remove the entire headgroup from the lipid. These were 
also initially reported in tissue extracts from brain and 
liver (Hawthorne, 1964; Hawthorne and White, 1975). TPI 
phosphodiesterase activity (reaction 7) in brain is found in 
soluble and in plasma membrane-enriched fractions, but in 
kidney and iris smooth muscle it appears to be soluble 
(Lapetina et~., 1975; Akhtar and Abdel-Latif, 1980). By 
contrast, 
possess 
tightly 
the erythrocytes of man and several other species 
a PPI phosphodiesterase (reaction 7 and 8) that is 
associated with the plasma membrane (Allan and 
Michell, 1978; Downes and Michell, 1981; Downes and Michell, 
1982). PPI 
activated by 
phosphodiesterases share 
calcium ion. However, 
different enzymes. 
an ability 
they appear 
to 
to 
be 
be 
Irving et~· (1979) have revealed a complex pattern 
of control of PPI rat brain phosphodiesterases, in which the 
expressed activity varies according to the physio-cheffiical 
state of the substrate phospholipid within the membrane. 
Phosphatidylinositol Effect (PI Effect) 
In 1953, Hokin and Hokin reported that acetylcholine 
stimulated the incorporation of radioactive phosphorus into 
Phospholipids of the pigeon pancreas in vitro. In a 
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subsequent paper (Hokin and Hokin, 1955), these 
investigators demonstrated that the specific phospholipids 
responsible for the effect were phosphatidylinositol (PI) 
and phosphatidate (PA). This phenomenon by which stimuli 
enhance the radioactive labeling of phosphatidylinositol has 
been generally termed the 'phosphatidylinositol effect' or 
'pr effect. ' 
By the early 1960s, interest in the 
phosphatidylinositols (PPis) focused on two phenomena. The 
first was that a stimulation of the metabolism of PI might 
play a special role in receptor-mediated responses of cells 
to external stimuli such as hormones or neurotransmitters 
(Michell, 1975; 1979; Marx, 1984). These responses were 
orig in ally detected in acetylcholine- or pancreozymin-
treated pancreas as a rapid increase in the incorporation of 
radioactive phosphate or inositol into PI and PA, a 
precursor of PI. 
Another important finding was that the phosphate 
groups of DFI and TPI showed rapid metabolic turnover. In 
many cells the metabolic turnover of the monophosphates of 
the whole polyphosphoinositide pool can occur within a few 
minutes. This rapid rcte of turnover and the subcellular 
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localization of PPI suggest that these lipids may 
participate in some ubiquitous function of the plasma 
membrane. 
The PI Response in the Function of Receptors 
The ultimate aim of biochemical research into the mode 
of action of neurotransmitter receptors is to determine the 
sequence of events between receptor occupancy and the final 
physiological response. On their arrival at the surface of 
a responsive cell, most intracellular messages, including 
neurotransmitters, antigens, and many hormones, are read and 
interpreted by receptors exposed on the exterior of the 
cell. But the cellular responses to such chemical messages 
frequently occur at intracellular sites. Mechanisms must 
therefore exist for the translation of these signals into a 
language understandable within the cell. The link between 
receptor activation and cellular response is mediated b " 1 
various effectors. 
A great deal of evidence supports the notion that 
inositol phospholipid breakdown is an eirly event in the 
receptor-response cascade (Table VI) and that the lipid 
hydrolysis step may be a coupling reaction which is 
essential for normal receptor function (Redman and Hokin, 
1964; Reddy and Sastry, 1979; Hokin-Neaverson ~! ~·, 1978). 
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Table VI 
RECEPTOR COUPLED TO PHOSPHOINOSITIDE TURNOVER 
IN TARGET TISSUES (ABDEL-LATIF ET AL., 1974) 
Tissue 
Iris smooth muscle 
Hepatocytes 
Parotid gland 
Platelets 
Brain (nerve 
ending preparations 
or slices) 
Avian salt gland 
Blowfly salivary 
gland 
Adrenal gland 
Pancreas 
Receptor 
Muscarinic cholinergic, ~ 1-adrenergic 
Vasopressin, angiotensin 
Muscarinic cholinergic, ~ 1 -adrenergic Substance P 
Thrombin, ADP, 
Platelet activating factor 
Muscarinic choliergic, ACTH 
Muscarinic cholinergic 
Serotonin 
ACTH 
Muscarinic cholinergic, caerulein 
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The Hokins first demonstrated that activation of 
certain receptors (e.g., muscarinic cholinergic or~1 -
adrenergic) resulted in increased incorporation of added 
radioactive phosphorus into PA and PI. It was subsequently 
reported that there was a net loss of PI upon stimulation 
with the accumulation of an approximately equivalent amount 
of PA (Hokin-Neaverson, 1974b). This was thought to arise 
from an initial phosphodiesteratic breakdown of PI, 
liberating diacylglycerol (DAG), which was in turn rapidly 
rephosphorylated in the presence of radioactive ATP to yield 
radiolabeled PA. The PA was then proposed to be converted 
to PI via (CDP-DAG), completing a 'phosphatidate-
phosphatidylinositol cycle' (Figure 5). Despite this 
observation and the known metabolic interrelationship 
between the inositol lipids, a direct effect of receptor 
activation on DPI and TPI turnover was not proposed or 
examined further until 1977, when Abdel-Latif and colleagues 
demonstrated that exposure of the iris smooth muscle to 
acetylcholine resulted in increased breakdo~n of 
radiolabeled TFI. These experiments, as well as a number of 
other indirect indications, led to intensified efforts to 
identify changes in PPI associated with receptor activation. 
There are now numerous documented examples of receptor-
ligand interactions linked to PPI turnover in brain tissue 
Figure 5 
PHOSPHATIDATE-PHOSPHATIDYLINOSITOL CYCLE 
(HOKIN-NEAVERSON, 1974b) 
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(Table VII) and specifically muscarinic cholinergic 
receptors (Table VIII). In most instances, these have been 
measured by loss of PPI radioactivity from radiolabeled 
inositol or prelabeled cells. Such studies indicate that 
radiolabeled TPI, and in some cases DPI as well, is rapidly 
diminished following addition of a specific ligand. For 
example, 20% or more of label in TPI is lost within 5-30 
seconds of exposure of platelets to thrombin, of hepatocytes 
to vasopressin, or of parotid gland slices to rnethacholine 
(Table VI). There is also evidence in the iris smooth 
muscle, in platelets, and in blowfly salivary gland of 
simultaneous release of inositol triphosphate with receptor 
activation. The rapidity with which the lipid breaks down 
following ligand addition suggests that the cleavage of TPI 
rather than PI constitutes the initial event following 
receptor activation and that the disappearance of PI is a 
secondary response that reflects the process of 
replenishment of the depleted polyphosphoinositide pool. 
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Table VII 
RECEPTOR-COUPLED INOSITOL PHOSPHOLIPID HYDROLYSIS 
IN NEURONAL TISSUE (DOWNES, 1982) 
RECEPTOR TYPE 
MUSCARINIC CHOLINERGIC 
{SOME) 
..t1-ADRENERGIC 
SFROTm~n; 
SUBSTAh'CE P 
NEUROTEKSIK 
V1-VASOPRESSIN 
CCK-OC'l'APEP'I·IDE 
NERVE GRO'i'i'TH FACTOR 
LOCATION 
MOST BRAIN REGIONS, 
SUPERIOR CERVICAL 
GANGLIA 
CEREBRAL CORTEX 
MOST BRAIN REGIONS 
CEREBRAL CORTEX 
HYPOTHALAMUS, STRIATU!-i, 
SUBSTANTIA NIGRA 
HYPOTHALAMUS 
HIPPOCAMPUS 
CEREBRAL CORTEX 
PC12 CLONAL RAT CELLS 
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Table VIII 
THE EFFECTS OF AGONISTS ON MUSCARINIC CHOLINERGIC 
RECEPTORS (BIRDSALL AND HULME, 1976) 
CLASS OF RESPONSE 
Class 1: high 
dose-response, 
related to 
agonist-receptor 
interaction 
Class 2: high 
dose-response, 
Ca independent 
Class 3: high 
dose-response, 
measure of Ca 
perrneabi li ty 
Class 4: high 
or moderate 
dose respor.se, 
mediated by 
Ca 
Class 5: lov.' 
dose-response, 
ex arr, pl e of 
'physiological' 
responses 
mediated by Ca 
RESPONSE 
Calculated agonist-receptor interaction 
curve derived from dose-ratio studies 
(Carbamylcholine 20 uM). 
Competitive inhibition of reversible 
binding of QNB to receptor sites 
(Acetylcholine 2-4 uM) 
Competitive inhibition of irreversible 
bin6ins of propyl benzilylcholinc 
mustard to receptor sites 
(Carbamylcholine 20 uE) 
Phosphatidylinositol breakdown, measured 
directly or detected through increased 
labeling (Acetyl- and carba~ylcholine) 
Calcium ion efflux from preloaded 
tissue (Carbamylcholine 50 uM) 
Potassium ion efflux from preloaded 
tissue (Carbamylcholine 30 uM) 
Electrical conductance of cell surface 
membrane (Carbarnylcholine >50 wl} 
Elevation of tissue cyclic GMP 
concentrations (Carbarnylcholine 0.1 uM) 
Protein secretion (Acetylcholine 0.1 uM) 
Contraction (Carbamylcholine 0.1 uM) 
CHAPTER III 
MATERIALS AND METHODS 
Animals 
Proven breeder males and female Sprague-Dawley albino 
rats were purchased from Holtzman Co. (Madison, WI). The 
female rats were between 45 and 60 days of age and weighed 
between 180 and 230 grams at the start of each study. The 
females were mated with proven breeder males prior to 
administration of the liquid diet. A male was added to each 
cace of the in~ividuaJlv housed females for a five day 
period. 
cho~. 
Diet 
During this time both animals were given access to 
All studies employed a dietary protocol calling for a 
prolonged period (3 weeks to 2 months) of consumption of a 
liquid diet containing chlordecone. 
Chlordecone (5, 15, or 30 mg/kg/day} and control 
isocaloric liquid diets were prepared as described by Druse 
~al. (1981). Protein, fat, and carbohydrate accounted for 
21.1%, 29.3%, and 49.6% of the calories, respectively. 
Isocaloric and chlordecone diets differed in only one 
respect: 5, 15, or 30 mg/kg/day of chlordecone was added to 
the chlordecone diet. The composition of the control diet 
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is described in Table IX. Daily feedings (following a pair-
feeding paradigm) were given to individually housed control 
and chlordecone animals. Pair-feeding was accomplished by 
feeding the control animals the same amount of diet that the 
chlordecone animals consumed the previous day. The animals 
were maintained on a 12 hour light-12 hour dark schedule 
with lights on at 8:00 a.m. 
Administration of Diets 
Female rats were given the liquid diet ad libitum the 
day after the proven breeder males were removed from the 
cages. The pregnant females were maintained on the 
chlordecone {K) or control {C) diets throughout gestation 
and/or lactation. Females fed liquid diet only during 
gestation were fed laboratory chow exclusively after 
parturition. Laboratory chow {Wayne Lab-Blox MRH 22/5, 
Wayne Laboratories, Chicago, IL) contains protein (26%), 
carbohydrate (61%), fat (13%), and salt mixture and vitamin 
fortification (<1%). Rats had free access to water at all 
times. In all studies the litter size was adjusted to 10 
pups at three days postpartum. 
Animal Sacrifice anQ Tissue Preparation 
Rats were killed by decapitation at 17 days, 24 days, 
31 days, 3 months, or 9 months. Brains were quickly re~oved 
Table IX 
LIQUID DIET 
Ingredient Grams/Liter 
Protein: 
Casein 47.95 
L-Cysteine 0.63 
L-Methionine 0.37 
Sego 3.75 
Carbohydrates: 
Maltose-Dextrins 114.00 
D12xtrose: \ 7 i ta~ .. .i:.i 
Mixture 5.00 
Sego 15.00 
Fats: 
Corn Oil 4.35 
Olive Oil 26.90 
Safflower Oil 
(78% Ethyl Linoleate) 3.50 
Sego 0.75 
Salt Mixture: 10.00 
Calories 
225 
5 30 
313 
Total Calories: 1068 
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% Calories 
21.1% 
49.6% 
29.3% 
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by cutting the skull along the sagittal and parieto-
occipital sutures and scooping from the ventral side. Brain 
preparations for synaptosomes and SPMs contained whole brain 
excluding the pons-medulla, brain stem and cerebellum. 
cerebral hemispheres and striatum were used for receptor 
binding studies and striatum and hypothalamus for biogenic 
amine levels. 
Synaptosomes and Synaptic Plasma Membrane Preparation 
During mechanical homogenization of brain tissue, the 
nerve terminals are sheared off. In isotonic solution, the 
nerve C - ,. c. .• sEc.l anc form 
Differential centrifugation techniques can be used to 
separate synaptosomes from cell nuclei, myelin, microsomes, 
mitochon6ria, and other subcellular co~ponents. 
Synaptosomes contain a characteristic self-limiting 
membrane, the synaptic cleft region, pre synaptic 
mitochondria and vesicles, and other substructures. After 
synaptosomes are hypotonically lysed, the synaptic plasma 
membranes {SPM) can be separated from remnant myelin 
fragments and presynaptic mitochondria and vesicles by 
differential centrifugation techniques. 
In the present study, synaptosomes and synaptic plasma 
membranes were prepared following a procedure of Cotman and 
Matthews (1971) {See Figure 6). Animals were sacrificeci as 
Figure 6 
SYNAPTOSOME AND SYNAPTOSOMAL PLASMA MEMBRANE 
ISOLATION PROCEDURE (COTMAN AND MATTHEWS, 1971) 
Fresh brain tissue 
J. 
20% (w/v) homogenate in 0.32 M sucrose, pH 7.0 
.1 
dilute to 10% (w/v) homogenate in 0.32 M sucrose 
J, 
10% Hl (tissue homogenate) 
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' i 
cfg at 3000 rpm (1000-llOOg), 5 min 
Pl (discard) Sl (supernatant) 
<_n_u_c_l_e_a_r __ p_e_1 __ 1e __ t_l ____ -1J cfg at 13,700 rpm (17,000xg), 20 min 
' =:!. S2 (discard) P2 (crude mitochondrial pellet) 
I 
suspend in 15 ml 0.32 M sucrose by hand homogenization 
.i J, cfg at.. 11,000 rpm (11,00Gxs), 20 rr,ir, 
S3 P3 
... 
0.32 M 
7.5% 
Ficoll 
13% 
Ficoll 
Suspend in 7 ml 0.32 M sucrose 
by hand homogenization 
Layer onto Ficoll-sucrose gradient 
l 
~fg ~t 22,000 ~pm (63,58l~g) 
in S\,-27 (or Sh-28), 45 rr,in 
Synaptosornal material found at the 7.5/13% 
interface. Remove interfacial material 
synaptosornal preparations. For SPM, dilute 
ficoll-sucrose 
and use for 
with 4 vol un.es 
0.32 i': sucrosE:. l cfg at 24,250 
rpm (106,000xg) 30 min 
0.32 !Ii 
25% 
32% 
35% 
3 8 >a 
Pellet 
1 osmotic shock in 6 wM Tris, pH 8.1 1.5 hr cfg at 20,300 rpm (54,500xg), 15 min 
Pe 11 et 
1 
resuspend in 7 ml sucrose, layer on 
. gradient and cfg 22,0CO rpm, 1.5 hr 
SPMs found at 25/32.5% (w/v) interface 
Dilute interface in 4 vols 0.1 mM EDTA 
.l,. cfg at 24,230 rpm (106,000xg) .30 min 
Pellet used for SPM determinations 
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described above. Cerebral hemispheres were homogenized, 20% 
(w/v), in cold, 0.32 M sucrose (pH 7.0) in a glass 
homogenizer using a motor-driven teflon coated pestle. The 
homogenizer and pestle were rinsed with an equal volume of 
0.32 M sucrose (pH 7.0). The rinse and homogenate were 
combined so that the final concentration of the homogenate 
was 10% (w/v). All subsequent steps were done at 0-4 o C. 
An aliquot (0.5-1.0 ml) was then removed for protein 
determination. 
The homogenate was centrifuged in a refrigerated (0-
4 °c) DuPont 8orvall RC-SB at 3,000 rpm (1,000-1,100 X g) 
for 5 minutes usin9 a 8orvall 88-34 rotor. This resulted in 
a crude nuclear pellet (P1 ), containing cell bodies and 
nuclei, and a supernatant (81). The supernatant (81 ) was 
decanted from the nuclear pellet and centrifuged at 13,700 
rpm (17,000 X g) for 10 minutes in the Sorvall. After this 
centrifugation, the supernatant (S2 ) was decanted. The 
crude mitochondrial pellet (P2 ) was resuspended in 15 ml of 
cold 0.32 M sucrose (pH 7.0) by hand homogenization using a 
smooth, round bottom, glass hand-held homogenizer with a 
teflon pestle. The suspension was centrifuged at 11,000 rpm 
(11,000 X g) for 20 minutes in the 8orvall. The resulting 
supernatant (S3) was decanted and discarded, and the pellet 
(P3) was resuspended in 7.0 ml of 0.32 M sucrose (pH 7.0) by 
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hand homogenization. An additional, optional rinse was 
omitted. The suspension was layered on top of a Ficoll 
gradient consisting of 13.5 ml of 13.0% (w/v) Ficoll in 0.32 
M sucrose (pH 7.0) which had been previously overlayered 
with 13.5 ml of a 7.5% (w/v) Ficoll-sucrose solution (pH 
7. 0 ) • The gradient was centrifuged at 22,000 rpm (63,500 X 
g) for 45 minutes. This and all subsequent centrifugations 
were performed 
utilized either 
centri fugations 
device. 
in a Beckman L 
the SW-27 
5-65 
or 
ultracentrifuge 
SW-28 rotor. 
and 
All 
were stopped by an electrical braking 
Crude myelin was found at the 0.32 M sucrose/7.5% 
Ficoll-sucrose interface. Synaptosomal material was found 
at the 7.5/13.0% Ficoll-sucrose interface. The synaptosomal 
material was removed, diluted with 4 volumes of 0.32 M 
sucrose (pH 7.0) anc centrifuged at 24,250 rpm (106,000 X g) 
for 30 minutes. 
in 
The supernatant was decanted and the pellet 
a small volume of phosphate buffer for resuspended 
phospholipid stimulation experiments or resuspended in 
smal 1 vol urr,e of 0. 32 l,i sucrose for synaptic plasrr,a membrane 
(SP~l) isolation. The pellet was then osrnotically shocked 
for 1. 5 hours ( 0-4 ° C) by res us pending it in 6 ml>: Tris (pH 
8.1). It was shown by Cotman and Matthews (1971) that 
osmotic shock at alkaline pH (pH 8.1) for 1.5 hours is 
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necessary for the subsequent resolution of synaptosomal 
mitochondria from the synaptic plasma membrane. The 
suspension was centrifuged at 20,300 rpm (54,500 X g) for 15 
minutes. The pellet was resuspended in 7 ml of 0.32 M 
sucrose and layered onto a sucrose gradient consisting of 
the following sucrose solutions in order of decreasing 
density (heaviest on the bottom): 5 ml of 38.0% (w/v), 7.5 
ml of 35.0% (w/v), 7.5 ml of 32.5% (w/v), and 7.5 ml of 
25.0% (w/v) sucrose. The gradient was centrifuged at 22,000 
rpm (63,500 x g) for 1.5 hours. Synaptic plasma membrane 
fragments were found at the 25/32.5% (w/v) sucrose 
interface. The SPM bands were removed with clean Pasteur 
pipet~ and diluted with 0.1 M EDTA. 
Radiolabeled Phosphorus Incorporation into Synaptosomes 
Radiolabeled phosphorus incorporation into 
synaptosomes was assessed using a modified procedure of 
Abdel-Latif et al., 1968). Prepared synaptosornes were 
pooled in groups of 3 animals and suspended in approximately 
0. 5 ml of buffer (McMurray et ~·, 1963). The buffer 
contained 0.013 M sodium pyruvate, 0.002 M magnesium 
chloride, 0.005 M NAD, 8.3 X 10-4 M cytochrome c, 0.0025 ~ 
A.MP, 0. 012 M Na F, 0. 0 0 5 t-~ NaH PO , 
2 4 
0.0005 M CTP, 0.015 ~ 
Tris-HCl (pH 7.4), 0.75 ml< calcium ion, 10 mM glucose and 10 
rrJ·: sodiu;;, succinc.te. The synaptosomes were diluted so that 
the mi 11 igrams 
approximately 
(approximately 
of protein per milliliter 
equal. Radiolabeled 
100 uCi/flask) was added 
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of buff er were 
orthophosphate 
to the buffer-
synaptosome mixture and incubated in open Erlenmeyer flasks 
(25 ml capacity) for one hour with shaking in a water-bath 
at 37 °c. 
After incubating for one hour, the samples were 
divided into two sets of test tubes for addition of agonist 
alone, antagonist plus agonist or antagonist alone. The 
agonists and their respective antagonists are listed in 
Ta0le X. 
The antagonist was added to the respective tubes and 
incubated for 5 minutes. After the incubation period, 
respective agonists 
reincubated for 30 
were added to the required tubes and 
minutes. The reaction mixture was 
terminated by the addition of 2 ml chloroform, 5 ml methanol 
and 0.5 ml of 0.1 M EDTA-2 M KCl. 
Extraction and Analysis of Phospholipids 
After the incubation was terminated as described 
above, the synaptosomal samples were partitioned by the 
method of Cohn et al. (1978). The samples were left for twc 
hours at roorr temperature or overnight at 5 °c. Then 2 ml of 
chloroforF and 1 rrl of EDTA-KCl was added to each sample and 
Table X 
AGONISTS AND THEIR RESPECTIVE ANTAGONISTS 
USED FOR PHOSPHOLIPID STIMULATION STUDIES 
77 
Agonist Concentration Antagonist Concentration 
Carbamylcholine 1 mM Atropine 50 uM 
Dopamine 10 mM Haloperidol 1 mM 
Eoracrer;a lir.2 lC' -~.,.. Regitine 1 m~: .i.; ·~ 'J. 
Histamine 5 m.M Bentazole 5 mM 
Serotonin 10 mM 
---------
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vortexed. The samples were centrifuged at 1000 X g and the 
resulting chloroform layer (bottom layer) removed. The 
aqueous phase was washed twice with 3 ml of chloroform, 
centrifuged and the resulting chloroform layers combined. 
The phospholipids were evaporated to dryness under a gentle 
stream of nitrogen and stored in benzene at -20 °c until 
further analyzed. 
The phospholipids were analyzed by thin layer 
chromotography (TLC) using the method of Graff et al. 
(1984). The phospholipid samples were thawed and dried 
under nitrogen. For analysis of radioactive content of 
individual phospholipids, a portion of each sample was 
spotted on a 1 cm lane in one corner of a 20 cm by 20 cm, 
500 micron, silica gel G plate that had previously been 
activated in a 110 ° C oven for one hour. The plates were 
developed 
phospholipid 
in two dimensions 
classes. The 
for 
solvent 
resolution 
used in 
of 
the 
major 
first 
direction was chloroform: methanol: amrooni un-, hydroxide: 
water (60:30:4:1) (vol:vol). After the first dimension, tte 
plates were thoroughly dried under nitrogen for 15-30 
minutes. The second dimension solvent consisted of 
chlorofor~: acetone: methanol: glacial acetic acid: water 
(40:15:13:12:8) (vol:vol). Tentative identification of 
phospholipid classes was accomplished by comparison of the 
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migration of standard phospholipids to samples. The 
positions of the phospholipids were marked on plates that 
had been exposed to iodine vapors or sprayed with sulfuric 
acid (50% in water) and placed in a 110 °c oven for 
visualization. After sublimation of the iodine or sulfuric 
acid, positions of the silica gel corresponding to the 
positions of the phospholipids were scraped into vials. One 
ml of water was added to the vials and the samples vortexed. 
-
Ten ml of Aquasol f luor was added to the vials prior to 
liquid scintillation counting. The radioactivity of the 
orthophosphate incorporated into the individua1 phospholipid 
classes was measured in a Packard scintillation counter. 
Remaining sample aliquots were used to determine total 
phospholipid phosphorus by the procedure of Lanzetta et al. 
(1979). To each sample 100 ul of 70% perchloric acid (PCA) 
was added and the samples digested in a 170 ° C heating block 
for 90 minutes to hydrolize the phosphate from the 
phospbolipid. After cooling, the samples were adjusted to 
120 ul by ad6ition of ~ater. Then 800 ul of color reagent 
(90 rr,l 0.045':; malachite green oxalate, 30 r1.1 4.2% amrr:oniu:-, 
molybdate in 4 N HCl and 5.0 ml sterox) was added and the 
mixture \'ortexed. After 30 minutes of color 
development, the absorbance was read at 660 nm on a 
spectrophotometer. 
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Protein Determination 
Protein determination was performed following the 
procedure of Bradford (1976). Crystalline bovine serum 
albumin (BSA) was used as the protein standard. A standard 
1 ml BSA protein/ ml solution was prepared in deionized 
water. Protein standards contained 0 ug (reagent blank) to 
20 ug BSA. Absorbance was measured at 700 nm in a Beckman 
spectrophotometer. 
Receptor Binding 
Off spring of control and chlordecone-exposed rats were 
decapitated and their brains rapidly removed. After 
excision of the cerebella, which were nearly devoid of 
receptor activity as determined by Yamamura and Snyder 
(1974), each brain was diluted to 0.66 mg tissue/ml of ice-
cold sodium-potassium {monobasic-dibasic) phosphate buffer 
{pH 7.4). The brains were homogenized in a glass 
homogenizer fitted with a teflon pestle. The homogenate was 
centrifuged for 10 minutes at 1000 X g (4°C). The pellet 
{crude nuclear fraction) was discarded and the resultant 
supernatant used for receptor binding studies. For 
muscarinic receptor binding studies, tritiated quinuclinidyl 
benzilate (QNB) (30.2 Ci/mnole) was used as a ligand. Each 
determination was performed in quadruplicate together with 
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quadruplicate samples contaning atropine (10 uM) as a 
displacer to determine non-specific tritiated QNB binding. 
The samples were incubated for 60 minutes at 37 ° C; 
then the reaction was stopped by passing the contents 
through a cell culture filtration system positioned over a 
vacuum. The filters were washed twice under vacuum with 3 
ml of ice-cold buffer. The filters were then dried and 
placed in vials containing 5 ml of toluene phosphor fluor 
(toluene:PPO:POPOP) and the radioactivity determined in a 
Beckman LS 7500 (microprocessor controlled) liquid 
scintillation counter. 
For 
prepared 
Ci/mmole) 
displacer. 
dopamine receptor binding, brain tissue was 
as described above. Tritiated spiperone (24.5 
was used as a ligand and butaclamol (1 uM) as 
Samples were incubated for 15 minutes and 
processed as described above. 
Intergroup variation was analyzed using a linear 
regression Scatchard analysis program designed for an Apple 
computer (Scatchard, 1949). 
Chlordecone Levels 
Chlordecone levels were determined using a modified 
method of Moseman (1977). Whole brain excJuding cerebellum 
was homogenized in 2.5 ml of acetonitrile with a Sorvall 
Omni-~ixer at high speed fer approximately 30 seconds. The 
macerated tissue was separated from the 
centrifugation at 3000 rpm for 5 minutes. 
then removed by pasteur pipet and placed 
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solvent by 
The solvent was 
in a 50 ml 
centrifuge tube. The maceration/ extraction was repeated 
twice more and the extracts combined in the same centrifuge 
tube. The combined extract was mixed with 5 ml of 2% 
aqueous sodium sulfate (N°2S04 ) and partitioned with 2 ml of 
benzene. This extraction procedure was repeated twice more 
with 1 ml portions of benzene. The extracts were combined 
in a 10 ml test tube and evaporated to dryness with a gentle 
strea~ of nitrogen. The samples were diluted with e 
toluene-2% methanol mixture and injected into a Varian model 
3700 gas chromatograph with an electron-capture detector. 
Quantitation of chlordecone levels was performed by 
comparisons with peak heights from standard curves with 
varying amounts of chlordecone and a fixed cencentration of 
dieldrin. 
Catecholamine Extraction from Brain Tissue 
Hypothalamus (-45 mg) or striatum (-55 mg) from 
control and chlordecone exposed off spring was homogenized 
in 75% ethanol 20% (w/v). The internal standard DHBA was 
added to the homogena~e to estimate the percent recovery. 
The homogenized tissue was centrifuged at 16,000 rpm for 20 
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minutes at 0-4 ° C. The supernatant was poured into 5 ml 
vials and dried under a gentle stream of nitrogen. The 
dried sample was then diluted in 0.5 ml of mobile phase (0.1 
M phosphate, 0.5 mM OSA and 8% methanol at pH 3.85) and 
centrifuged in a Beckman microfuge for 2 minutes. The 
sample was then injected directly in to a high performance 
liquid chromatograph (HPLC) with a 5 uM Biorad 25 cm 
reverse phase column with a flow rate of 0.7 ml/minute 
attached to an electrochemical detector (0.7 volts). The 
resulting catecholamine peaks were quantitated by comparison 
to a standard curve of known concentrations. 
Statistical Determinations 
For each set of data except dopaminergic receptor 
binding and biogenic amine levels, data represent three 
animals from two separate groups. Numerical calculations 
were generally expressed as the mean + stanaara deviation of 
several determinations. Statistics on the aifference 
between two related groups (control and chlordecone-exposed) 
were performed using the Student's t-test of probability. 
CHAPTER IV 
RESULTS 
This study examined the off spring of female rats that 
were pair-fed a control or chlordecone (5, 15 or 30 
mg/kg/day) diet during gestation and lactation or during 
gestation only. Suckling neonates were maintained with 
their biological mothers (noncrossf ostered) or were 
crossfostered to control fed surrogate mothers. 
Diet Consumption and .Maternal Weight Gain 
Diet consu~ption cf females fed the liguid diet w~c 
100-120 ml/day which corresponded to 210-250 kcal/kg body 
weight and 11-13 g protein/kg. Control and 5, LS or 30 mg/kg 
chlordecone exposed mothers gained 150, 120, 100 and 90 
grams, respectively, during gestation (Table XI and Figure 
7). The discrepancy between the amount of weight gained 
during gestation could partially be accounted for by the 
fact that chlordecone exposed mothers gave birth to reduced 
litter sizes (Figure 8). However, after litter size 
adjustment two days postpartum, the body weights of 
chlordecone feo mothers did not recover to normal levels but 
were decreased to 85, 81 and 77% of control for 5, 15 and 30 
mg/kg/day chlordecone exposed mothers, respectively. 
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Table XI 
MATERNAL BODY WEIGHT OF RATS FED 0, 5, 15, AND 30 
MG/KG/DAY CHLORDECONE THROUGHOUT PREGNANCY AND 
LACTATION OR DURING PREGNANCY ALONE 
DAY 
1 
( % of C) 
8 
(% of C) 
15 
( % of C) 
22 
( % of C) 
29 
Noncrossfostered 
(% of C) 
Cross fostered 
(% of C) 
36 
Noncrossfostered 
( % of C) 
Crossf ostered 
(% of C) 
CONTROL (C) 5 MG/KG 15 MG/KG 30 MG/KG 
218+3 217+4 222+6 213+8 
ooo) C99T (102l <98) 
294+4 298+2 289+3 290+7 
(100) (lOI) (98) (9~) 
359+10 340+6 327+8 310+5* 
(100) (95) (91) (86) 
262+5 243+6* 232+4* 217+8* 
(100) (86) (82) (77) 
280+4 
(100) 
283+6 
( 100) 
284+6 
( 10 0) 
282+4 
{ 100) 
246+8 
( 88) 
260+7 
(92) 
241+5* 
(85) 
280+5 
(100) 
229+5* 
(82) 
240+3* 
< s~T 
230+3* 
{ 81 J 
247+6 
c 86 J 
218+3* 
(78) 
226+5* 
(80) 
220+4* 
( 77) 
233+5* 
( 8 L. ) 
Each value represents the mean of 14 animals + the standard 
deviation. An asterisk (*) indicates that body weights of 
control and chlordecone exposed mothers were significantly 
different at p<0.05. 
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Figure 8. Litter size of mothers exposed to chlordecone. 
Each value represents the mean of 12 litters + the standard 
deviation. An asterisk (*) and two asterisks-(~*) indicate 
that values from control and chlordecone exposed mothers 
are different at p<0.01 and p<0.001, respectively. 
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Therefore, during both gestation and lactation, chlordecone 
exposed mothers displayed significantly reduced body 
weights. When the chlordecone mothers were fed control 
diets during lactation, the body weights of 5 mg/kg exposed 
mothers were eventually rehabilitated. The 15 and 30 mg/kg 
exposed mothers still displayed reduced body weights but not 
as significantly different from normal as lactationally 
exposed mothers {Table XI). 
Body and Brain Weights 
Body weights of control and chlordecone exposed 
off spring were significantly different at all ages examined 
{Figure 9). At 17 days of age, body weights of 5, 15 and 30 
mg/kg exposed offspring were 63, 46 and 34~ of control, 
respectively {Table XII). This decline in body weight 
persisted at 24 and 31 days of age. Crossfostering of 
offspring postpartum could only partially rehabilitate the 
reduced body weights. 
free diet, the body 
cffspring (5, 15 or 
Even after 31 days of a chlordecone-
weights of gestationally exposed 
30 mg/kg) were still significantly 
reduced to 68, 42 and 36% of control (See Table XII and 
Figure 9). 
The brain weights of chlordecone exposed off spring 
were also significantly reduced at all ages but to a lesser 
degree than body weights. The brain weights of 17 day old 
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Figure 9. Body weights of chlordecone exposed offspring. 
Each value represents the mean of 20 animals + the standard 
deviatio~. An asterisk (*) and two asterisks c~~) indicate 
that values from control and chlordecone exposed offspring 
are different at p<0.01 and 0.001, respectively. 
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AGE (DAYS) 
Table XII 
BODY WEIGHTS OF CONTROL, 5, 15, AND 30 
MG/KG/DAY CHLORDECONE EXPOSED OFFSPRlNG 
BODY WEIGHT (GRAMS) 
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CONTROL (C) 5 MG/KG 15 MG/KG 30 MG/KG 
17 
Noncrossf ostered 
(% of C) 
Cross fostered 
(% of C) 
24 
Noncrossfostered 
( % of C) 
Crossf ostered 
(% of C) 
31 
Noncrossfostered 
( % of C) 
Cross fostered 
(% of C) 
35+1 
( 100) 
37+3 
( 100) 
76+4 
(100) 
74+4 
(100) 
110+6 
(100) 
107+8 
( 1 oc) 
22+3* 
( 63) 
28+1 
( 70) 
41+3** 
( 54) 
43+3** 
(SS) 
66+4** 
(62) 
74+3** (6 8) 
16+ 2 llr* 
c 4E) 
2 0+ 3 ** 
( 54) 
21+3** 
c28> 
24+2H 
c 32°) 
40+3*"' 
( .3 6) 
U-+5** (42> 
12+1** 
( 34) 
15+2** 
( 40) 
18+2** 
( 24) 
20+1** 
( 27) 
30+3** 
( 27) 
38+3** 
( 36) 
Each value represents the mean of 20 animals + the standard 
deviation. An asterisk (*) and two asterisks (~*) indicate 
that values from control and chlordecone exposed offspring 
are different at p<0.01 and p<0.001, respectiv€Jy. 
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offspring exposed during gestation and lactation were 63, 57 
and 45% of control for 5, 15 and 30 mg/kg, respectively. By 
31 days of age, the brain weights had partially recovered 
but were still significantly different from controls (See 
Table XIII and Figure 10). Crossfostering of offspring did 
not significantly affect the recovery of the brain weights. 
In long-term studies on 3 and 9 month old control and 
15 mg/kg crossfostered offspring, the body and brain weights 
were comparable. 
In summary, body and brain weights of chlordecone 
exposed offspring 17 to 31 days of age were significantly 
different from those of controls. Crossfostering of 
chlordecone exposed offspring did not rehabilitate body and 
brain weights. By 3 months of age, brain ana body weights 
of gestationallly exposed (15 mg/kg) offspring were 
comparable to those of control offspring. Therefore, 
chlordecone effects on body and brain weights persist at 
least 31 days after cessation of dosing. 
Brain Chlordecone Levels 
The whole brain (excluding cerebeL1um) chlordecone 
content (ug/g tissue) of all exposed offspring increased in 
a dose-dependent manner (Figure 11). By 17 days postpartum, 
all cortical chlordecone levels had reached a rnaximu~ 
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Table XIII 
BRAIN WEIGHTS OF CONTROL, 5, 15, AND 30 MG/KG/DAY 
CHLORDECONE EXPOSED OFFSPRING 
AGE (DAYS) BRAIN WEIGHT (GRAMS) 
CONTROL (C) 5 MG/KG 15 MG/KG 30 MG/KG 
17 
Noncrossfostered 1.70+.08 
(% of C) (100) 
Crossfostered 
( % of c) 
24 
1.68+.06 
(100) 
Noncrossfostered 1.72+.06 
(% of C) (100) 
Cross fostered 
(% of C) 
31 
1.75+.07 
(100) 
Noncrossfostered 1.74~.1 
(% of C) (100) 
Cross fostered 1.79+.l 
(% of C) (100) 
1.07+.09* 0.97+.05* 0.76+.l* 
(63) (57) (45) 
1.10+.l* 1.03+.04* 0.82+.l* 
(65) (63) (49) 
1.21+.0l* 1.08+.04* .96+.l* 
(71) (63) (56) 
1.32+.l* 1.12+.05* 1.00+.l* 
(76) (67) (59) 
1.32+.l* 1.30+.04* 1.12+.l* 
(78) (7.\) (64) 
1.40+.l* 1.36+.l* 1.20+.04* 
(80) (76) (68) 
Each value represents the mean of 20 animals + the standard 
deviation. An asterisk (*) indicates that values from 
control ano chlordecone exposed offspring are different at 
p<0.01. 
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Figure 10. Brain weights of chlordecone exposed offspring. 
Each value represents the mean of 20 animals + the standard 
deviation. An asterisk (*) indicates that the values from 
control and chlordecone exposed off spring are differer.t at 
p<0.01. 
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Figure 11. Chlordecone levels in cortical regions of 
chlordecone exposed offspring. Each value represents the 
mean of 8 animals + the standard deviation. An asterisk 
(*) and two asterisks (**) indicate that values from 5 
mg/kg are different from 15 mg/kg and 30 mg/kg exposed 
animals at p<0.01 and p<0.001, respectively. 
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concentration dependent on the daily dosage. The levels 
were 22, 38 and 52 ug/g tissue for noncrossfostered 5, 15 
and 30 mg/kg exposed offspring, respectively. Even though 
the offspring were continually exposed to the respective 
dosages, the cortical chlordecone concentrations remained 
constant at 24 and 31 days of age. Crossf ostering of the 
gestationally exposed offspring did not significantly reduce 
the brain chlordecone concentrations. Even at 31 days after 
cessation of dosing, the chlordecone levels decreased only 
1-5%. Three month old 15 mg/kg gestationally exposed 
offspring still retained a small (2 ug/g tissue) but 
detectable amount of chlordecone which was cleared by 9 
months. These findings are in agreement with similar 
studies (Fujimori et al., 1982) that chlordecone has a 
maximum accumulation rate and a slow clearance rate. 
Synaptosornal Protein and Phospholipid Content 
To assess whether chlordecone exposure affected 
protein 
total 
examined 
composition of synaptic plasma membranes 
protein 
by Dr. 
concentrations and distributions 
Daniel Selivonchick of Oregon 
(SPM), 
were 
State 
University. There were no significant differences in SPN 
protein concentrations and distributions between control and 
chlordecone exposed offspring at any of the ages or exposure 
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levels examined (Figure 12). Identical results were 
observed in crossfostered offspring. 
Phospholipids from control and chlordecone exposed 
offspring were extracted from SPM. The samples were 
analyzed 
individual 
for total phospholipid and distribution of 
phospholipid classes. 
distributions for noncrossfostered 
The 
and 
phospholipid 
cross fostered 
chlordecone exposed offspring are shown in Table XIV. The 
phospholipid composition of the chlordecone exposed 
offspring did not differ significantly from that of the 
control group. Phosphatidylcholine (PC) was the major 
membrane constituent followed by phosphatidylethanolamine 
(PE), phosphatidylinositols (PI), phosphatidylserine (PS), 
phosphatidic acid (PA) and phosphatidylglycerol (PG). These 
values are in agreement with previous findings by Fontaine 
et ~.(1980) on the phospholipid composition of synaptosomal 
membranes. 
Phospholipid S~imulation 
To determine whether specific receptors were coupled 
to enhanced phospholipid turnover, phospholipids were 
extracted 
pre labeled 
from agonist stimulated 32 P-orthophosphate 
synaptosomes (See Materials and Methods). 
Carbarnylcholine (CC), dopamine (DA), noradrenaline (NA), 
serotonin (SH~) or histamine (HA) were used as agonists to 
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Figure 12. Membrane protein concentrations of chlordecone 
exposed offspring. Each value represents the mean of 8 
animals + the standard deviation. 
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TABLE XIV 
PHOSPHOLIPID DISTRIBUTION OF SYNAPTIC PLASMA MEMBRANES 
FROM CHLORDECONE EXPOSED OFFSPRING 
GROUP PC PE PI PS PG PA 
17 DAYS NONCROSSFOSTERED 
----CONTROL 42 30 14 6 2 6 
5 MG/KG 40 29 14 8 2 7 
15 MG/KG 40 29 14 8 2 6 
30 MG/KG 40 30 15 7 3 5 
CROSSFOSTERED 
CONTROL 39 38 24 8 2 6 
5 MG/KG 40 30 15 7 3 5 
15 MG/KG 40 27 16 7 3 7 
30 MG/KG 39 29 14 8 3 7 
24 DAYS NONCROSSFOSTERED 
----CONTROL 44 31 12 7 2 4 
5 MG/KG 42 30 14 6 2 6 
15 MG/KG 43 28 15 7 2 5 
30 MG/KG 41 27 15 8 3 8 
CROSSFOSTERED 
CONTROL 44 31 12 7 2 4 
5 MG/KG 42 30 14 6 2 6 
15 MG/KG 43 28 15 7 2 5 
30 MG/KG 41 27 15 8 2 7 
31 DAYS NONCROSSFOSTERED 
CONTROL 46 27 13 7 2 5 
5 MG/KG 46 30 12 6 1 5 
15 MG/KG 44 31 12 7 2 4 
30 MG/KG 43 28 15 7 1 5 
CROSS FOSTERED 
CONTROL 46 30 12 6 1 5 
5 MG/KG 46 27 13 7 2 5 
15 .MG/KG 46 30 12 6 1 5 
30 MG/KG 45 28 13 7 2 4 
Units indicate percent of total phospholipids. Each value 
represents the mean of 3 animals + the standard deviation. 
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stimulate radiolabeled orthophosphate incorporation into 
phospholipids, specifically the phosphatidylinositols and 
phosphatidic acid. The incorporation of 32 P into 
triphosphatidylinositol (TPI), diphosphatidylinsoitol (DPI), 
phosphatidylinositol (PI) and phosphatidic acid (PA) 
represents subsequent resynthesis of the respective 
phospholipid after receptor-coupled breakdown. Therefore, 
the resynthesis of the respective phospholipids provides a 
convenient way to measure the extent of initial receptor 
stimulated breakdown. The antagonists atropine, 
haloperidol, regitine or bentazole were used in conjunction 
with CC, DA, NA or HA, respectively, or alone to elucidate 
whether any observed stimulation was due to receptor-
specif ic interactions. 
The results presented below deal specifically with 
receptor mediated stimulation of TPI, DPI, PI and PA 
turnover. When the distribution of radioactivity in various 
phospholipid components was determined, most of the 
radioactivity (>70%) was found associated with the inositol 
phospholipids and phosphatidic acid. For all agonists, the 
degree of stimulation was dependent on the phospholipid 
measured in the order of TPI> PA> DPI> PI such that similar 
effects were seen without regard to exposure levels. The 
total amount of stimulation for each phospholipid was 
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dependent on the concentration of chlordecone exposure in 
the order of control> 5 mg/kg > 15 mg/kg > 30 mg/kg and age 
in the order of 17 days< 24 days< 31 days. 
Antagonists added to the respective agonists or alone 
did not cause significant stimulation of phospholipid 
turnover above unstimulated control levels regardless of 
age or exposure levels except bentazole (discussed later). 
The remaining radioactivity 
phosphatidylcholine (PC) I 
was associated 
phosphatidylserine 
with 
(PS) I 
phosphatidylethanolamine (PE) and phosphatidylglycerol (PG) 
with each phospholipid containing 4-10% of the total label. 
For these four phospholipids, there were no significant 
differences 
offspring. 
between control and 
Carbamylcholine 
chlordecone exposed 
Muscarinic receptor coupling to inositol phospholipid 
turnover has been demonstrated by several investigators 
(Fisher et ~., 1983; Hokin-Neaverson, 1974). 
Carbamylchol ine was selected to determine whether the 
muscarinic receptor was affected by chlordecone exposure. 
Atropine was chosen as the antagonist to specifically link 
any observed stimulation to the M1 receptor. It has been 
demonstrated that atropine binds preferentially to the 1'\ 
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receptor by classic receptor/antagonist interactions, 
thereby blocking the receptor site from agonist binding. 
Carbamylcholine stimulation of 32p incorporation into 
synaptosomes of the control group was consistent with 
results obtained by Reddy and Sastry (1979) for developing 
brain. 
Appendix A and Figures 13-16 show the neurotransmitter 
effects of carbamylcholine. Carbamylcholine enhanced the 
specific activity of TPI, DPI, PI and PA in all groups. 
Seventeen day old off spring receiving 5 mg/kg/day 
chlordecone were not significantly different from the 
controls in any of the phospholipids measured. At 24 days 
of age, the effects were more pronounced in that they were 
significantly different from controls at the p<0.001 level 
for TPI and DPI and the p<0.01 level for PA. At 31 days of 
age, PI was also affected. The 15 and 30 mg/kg chlordecone 
exposed offspring displayed impaired stimulation by 
carbamylcholine at 24 and 31 days of age (p<0.001) for all 
phospholipids. 
Crossfostering of chlordecone exposed off spring 
appeared to have no effect on the amount of stimulation for 
any of the phospholipids examined versus noncrossfostereG 
offspring. Stimulation of synaptosomes from 3 and 9 month 
old gestationally exposed offspring (15 mg/kg) was still 
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Figure 13. 32 P incorporation into triphosphatidylinositol 
of synaptosomes from chlordecone exposed offspring: percent 
stimulation by carbamylcholine. Synaptosomes from control 
and chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with carbamylcholine for 
30 minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) and two asterisks-(**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 14. 32p incorporation into diphosphatidylinositol 
of synaptosomes from chlordecone exposed offspring: percent 
stimulatio~ by carbamylcholine. Synaptosomes from control 
and chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with carbamylcholine for 
30 minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals± the 
standard deviation. An asterisk (*) and two asterisks (**) 
indicate that values from control and chlordecone exposed 
Offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 15. 32 P incorporation into phosphatidylinositol of 
synaptosomes from chlordecone exposed offspring: percent 
stimulation by carbamylcholine. Synaptosornes from control 
and chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with carbamylcholine for 
30 minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) and two asterisks-(**) 
indicate that values from control and chlordecone exposed 
Offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 16. 32 P incorporation into phosphatidic acid of 
synaptosornes from chlordecone exposed offspring: percent 
stimulation by carbarnylcholine. Synaptosornes from control 
and chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosornes were then stimulated with carbamylcholine for 
30 minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) and two asterisks-(**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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significantly impaired relative to control 
was not significantly different from 24 or 
crossfostered offspring (15 mg/kg). 
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off spring 
31 day 
but 
old 
Addition of atropine to carbamylcholine preparations 
totally blocked the binding of carbamylcholine and negated 
any stimulation seen with carbamylcholine alone (100%±2). 
The incubation of synaptosornes with atropine alone did not 
display a significant stimulation over unstimulated controls 
(97%±2) of any of the phospholipids examined in all groups 
(Appendix B). 
To distinguish chlordecone effects on inositol 
phospholipid labeling from in vitro effects, the following 
experiments were performed and subsequent results obtained. 
Chlordecone was added to a control synaptosome preparation 
from 31 day old rats and incubated for 10 or 30 minutes. 
The synaptosomes were then labeled with radiolabeled 
orthophosphate and stimulated with carbarnylcholine. When 
the individual phospholipids were assayed there was no 
significant difference in control versus in vitro 
chlordecone exposed synaptosomes for any of the 
phospholipids (Table XV). 
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Table XV 
CARBAMLYCHOLINE STIMULATED RADIOLABELED ORTHOPHOSPHATE 
INCORPORATION INTO INOSITOL PHOSPHOLIPIDS AND 
PHOSPHATIDIC ACID OF SYNAPTOSOMES FROM 31 DAY 
OLD RATS EXPOSED TO CHLORDECONE IN VITRO 
GROUP TPI DP! PI PA 
CONTROL 
Carbamylcholine 142+4 127+2 121+3 139+5 
Carbamyl choline 
+ 103+3 100+4 101+2 100+1 
Atropine 
Atropine 100+2 97+1 98+3 992 
10 MINUTES 
Carbamyl chol ir.e 14C+3 l22+4 12 0+2 136+4 
Carbamyl choline 
+ 102+1 100+2 99+3 101+2 
Atropine 
Atropine 99+1 95+3 97+2 99+2 
30 MINUTES 
Carbamylchol ine 138+2 l26+3 116+3 134+3 
Carbamylchol ine 
+ 102+3 101+1 99+2 100+1 
Atropine 
Atropine 99+1 100+ 2 9 7+3 98+2 
Synaptosomes from 31 day old animals were preincubated with 
40 ug of chlordecone for 10 or 30 minutes and then incubated 
with radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with carbamylcholine for 
30 minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 3 animals ~ the 
standard deviation. 
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It was suggested that the decreased 
phosphatidylinositol labeling in chlordecone exposed 
offspring was a function of malnourishment. To test this 
protein-deficient offspring (courtesy hypothesis, 
Manteuffel) were substituted for chlordecone 
of Dr. 
exposed 
offspring and identical phospholipid labeling experiments 
were performed. Decreases in the magnitude of 
phosphatidylinositol and phosphatidic acid labeling were 
observed but not significant enough to fully account for the 
inhibition seen with chlordecone exposed offspring (Table 
XVI). 
In summary, carbamylcholine stimulated incorporation 
of 32P-orthophosphate into TPI, DPI, PI and PA was age and 
exposure dependent. The higher the exposure level, the 
more impaired the ability to cause muscarinic receptor-
coupled stimulation of phospholipid turnover. Even at 3 
and 9 months after cessation of dosing, stimulation was 
still significantly impaired. 
the brain (9 months) did 
Clearance of chlordecone fror. 
not alter the ability of 
carbamylcholine 
blocking of 
to stimulate phospholipid turnover. The 
carbamylcholine stimulated phospholipid 
breakdown by atropine demonstrates that the effects of 
chlordecone exposure were muscarinic receptor specific. 
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Table XVI 
CARBAMLYCHOLINE STIMULATED RADIOLABELED ORTHOPHOSPHATE 
INCORPORATION INTO INOSITOL PHOSPHOLIPIDS AND 
PHOSPHATIDIC ACID OF SYNAPTOSOMES FROM 
31 DAY OLD PROTEIN DEFICIENT RATS 
GROUP TPI DPI PI PA 
CONTROL 
Carbamylcholine 146+3 123+2 123+4 136+4 
Carbamylcholine 
+ 102+2 101+2 103+1 104+2 
Atropine 
Atropine 101+3 95+2 99+2 971 
PROTEIN DEFICIENT 
Carbamyl choline 143+2 120+3 117+3 133+2 
Carbamylcholine 
+ 100+1 10 l+ 3 97+2 98+4 
Atropine 
Atropine 97+2 96+2 98+ 3 97+1 
Synaptosomes from 31 day old protein aeficient animals were 
preincubated with radiolabeled orthophosphate for 1 hour. 
The prelabeled synaptosomes were then stimulated with 
carbamylcholine for 30 minutes. The reaction was terminated 
by adding 2 ml chloroform, 5 ml methanol, and 0.5 ml EDTA-
KCl. The phospholipids were extracted as described in 
Materials and Methods. Each value represents the mean of 3 
animals + the standard deviation. 
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Dopamine 
Dopaminergic receptor coupling to phospholipid 
turnover has been demonstrated only indirectly (Downes, 
1982). It has been suggested that the Dz receptor is 
coupled to phosphatidylinositol breakdown. Haloperidol is a 
potent antagonist that effectively blocks 98% of the D 
receptors at a concentration of 1 mM. Therefore, 
haloperidol in conjunction with dopamine provides a useful 
tool to associate phosphatidylinositol breakdown with 
specific D2 dopaminergic receptor stimulation. 
The effects of dopamine on radiolabeled orthophosphate 
incorporation into the phosphatidylinositols and 
phosphatidic acid of noncrossfostered chlordecone exposed 
offspring are represented in Figures 17-2Q and Appendix C. 
Similar 
earlier 
level, 
results were observed with dopamine as 
with carbamylcholine. The higher the 
the more significant the difference between 
described 
exposure 
control 
and chlordecone exposed offspring. The differences between 
the percent stimulation of the individual phospholipids of 
the control and exposed groups were less pronounced at 5 
mg/kg than at 15 or 30 mg/kg. The relative stimulation of 
the individual phospholipids increased with age froIT 17 to 
31 days of age. Therefore, the incorporation of 
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Figure 17. 32p incorporation into triphosphatidylinositol 
of synaptosomes from chlordecone exposed offspring: percent 
stimulation by dopamine. Synaptosomes from control and 
chlordeco~e exposec off spring were preincubated witr. 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with dopamine for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extractea as described in Materials anc 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) and two asterisks-(**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 18. 32 P incorporation into diphosphatidylinositol 
of synaptosomes from chlordecone exposed offspring: percent 
stimulation by dopamine. Synaptosomes from control and 
chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with dopamine for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) and ·two asterisks-(**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 19. 32p incorporation into phosphatidylinositol 
of synaptosomes from chlordecone exposed offspring: percent 
stimulation by dopamine. Synaptosomes from control and 
chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with dopamine for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) and two asterisks-(**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 20. 32 P incorporation into phosphatidic acid 
of synaptosomes from chlordecone exposed offspring: percent 
stimu la ti on by dopamine. Synaptos om es from control and 
chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with dopamine for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals± the 
standard deviation. An asterisk (*) and two asterisks (**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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orthophosphate into TPI, DPI, PI and PA were exposure- and 
age-dependent. 
When synaptosomal preparations were incubated with 
haloperidol and dopamine or haloperidol alone, there were no 
significant increases over unstimulated controls for any of 
the phospholipids examined (Appendix D). Therefore, the 
phospholipid breakdown observed with dopamine was due to a 
o 2 receptor-coupled response. 
Noradrenaline 
Several investigators (Abdel-Latif and Smith, 1974) 
have demonstrated that ~ 1-adrenergic receptor activation is 
coupled to inositol phospholipid turnover in cerebral cortex 
and other target tissues. Noradrenaline is a catecholamine 
which binds 
stimulatory 
addition of 
to ~l -adrenergic receptors to elicit 
response. That action can be blocked by 
a 
the 
regitine which is a potent .( 1 -adrenerg ic 
receptor antagonist. Therefore, noradrenaline 
phosphatidylinositol turnover should be effectively 
by regitine if such breakdown is specifically 
adrenergic receptor associated event. 
coupled 
blocked 
an ~ 1 -
'Ihe effects of noradrenaline associated 
phosphatidylincsito~ and phosphatidic acid breakdown are 
seen in Figures 21-24 and Appendix E. As was observed 
with carbamylcholine and dopamine, the incorporation of 
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Figure 21. 32 P incorporation into triphosphatidylinositol 
of synaptosomes from chlordecone exposed off spring: percent 
stimulation by noradrenaline. Synaptosomes from control and 
chlordecone exposed offspring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with noraarenaline for 30 
minutes. The reaction was terrninatea by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) and two asterisks-(**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 22. 32 P incorporation into diphosphatidylinositol 
of synaptosomes from chlordecone exposed offspring: percent 
stimulation by noradrenaline. Synaptosomes from control and 
chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with noradrenaline for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk {*) and two asterisks-(**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 2 3. 32 P incorporation into phosphatidylinosi tol 
of synaptosomes from chlordecone exposed offspring: percent 
stirr.u la ti on by nor a dren a 1 ir.e. Synaptosomes from contro 1 and 
chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with noradrenaline for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals± the 
standard deviation. An asterisk (*) and two asterisks (**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 24. 32 P incorporation into phosphatidic acid 
of synaptosomes from chlordecone exposed offspring: percent 
stirr:u la ti on by noradrena 1 ine. Synaptosomes from contro 1 and 
chlordecone exposed offspring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with noradrenaline for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals± the 
standard deviation. An asterisk (*) and two asterisks (**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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radiolabeled orthophosphate into TPI, DPI, PI and PA was 
exposure- and age-dependent. The relative percent 
stimulation within groups and between groups paralleled the 
results seen for both carbamylcholine and dopamine, the 
only difference being that the total amount of stimulation 
for each individual phospholipid was greater with 
noradrenaline than with the two other agonists. 
Addition of regitine to the incubation mixture prior 
to noradrenaline negated any subsequent phospholipid 
stimulation (Appendix F). Therefore, receptor activation 
and inositol phospholipid breakdown appeared to be linked 
specifically to the<>'l. 1 -adrenergic site. 
Serotonin 
Serotonin 
receptor-coupled inositol phospholipid 
hydrolysis has been demonstrated in cerebral cortex (Downy, 
1982) and in blowfly salivary gland (Reddy and Sastry, 
1974). Doubts have been expressed as to whether this 
alliance between the serotonin receptor and inositol 
phospholipid breakdown is specific as such. This is due to 
the inability to demonstrate antagonist blockage of the 
stimulatory effects. Antagonists to serotonin receptors 
exist, but they are not specific enough to block greater 
than 60% of the receptor sites. Therefore, for this study, 
138 
serotonin stimulated phospholipid breakdown was represented 
without reference to receptor specific activation due to the 
lack of an appropriate antagonist. 
Serotonin stimulated incorporation into the inositol 
phospholipids and phosphatidic acid (Figures 25-28 and 
Appendix G) paralleled the results seen previously with CC, 
DA and NA. There was a slightly greater overall stimulation 
seen with serotonin than with noradrenaline. However, the 
degree of stimulation seen with serotonin cannot be 
specifically associated with a serotonergic receptor 
mediated breakdown of inositol phospholipids. 
Histamine 
Receptor coupled inositol phospholipid breakdown by 
histamine had 
(Downy, 1982). 
both the H1 
been investigated in most brain regions 
This resultant turnover has been coupled to 
and H2 receptors. This study specifically 
focused on the H1 receptor activation in which bentazole can 
be used as an antagonist. 
The relative total stimulation of TPI, DPI, PI and Ph 
were comparable in all aspects to the effects seen with 
dopamine (Figures 29-32 and Appendix H). But the magnitude 
of these effects can not be specifically linked to the H1 
recepto~. Additio~ of be~tazole to the incubation mixture 
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Figure 25. 32P incorporation into triphosphatidylinositol 
of synaptosomes from chlordecone exposed offspring: percent 
stimulation by serotonin. Synaptosornes from control and 
chlordecone exposed offspring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with serotonin for 30 
minutes. The reaction was terminated by adding 2. ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) and two asterisks-(**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 26. 32 P incorporation into diphosphatidylinosi tol 
of synaptosomes from chlordecone exposed offspring: percent 
sti mu la ti orc by serotonin. Synaptosomes from control and 
chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with serotonin for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals± the 
standard deviation. An asterisk (*) and two asterisks (**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001~ respectively. 
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Figure 27. 32 P incorporation into phosphatidylinositol 
of synaptosomes from chlordecone exposed offspring: percent 
stimulation by serotonin. Synaptosomes from control and 
chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with serotonin for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals± the 
standard deviation. An asterisk (*) and two asterisks (**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 28. 32 P incorporation into phosphatidic acid 
of synaptosomes from chlordecone exposed offspring: percent 
stimulation by serotonin. Synaptosornes from control and 
chlordecone exposed offspring were preincubated with 
radio labeled orthophospLate for 1 hour. The pre labeled 
synaptosomes were then stimulated with serotonin for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) and two asterisks-(**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 29. 32 P incorporation into triphosphatidylinositol 
of synaptosomes from chlordecone exposed offspring: percent 
stimulation by histamine. Synaptosomes from control and 
chlordecone exp0s~d cff spri~g were preincubated ~ith 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with histamine for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) and two asterisks-(**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 3 0. 32 P incorporation into aiphosphatidylinosi tol 
of synaptosomes from chlordecone exposed offspring: percent 
stimulation by histamine. Synaptosornes from control and 
chlordecone expose6 off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with histamine for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) ana two asterisks-(**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 31. 32 P incorporation into phosphatidylinositol 
of synaptosomes from chlordecone exposed offspring: percent 
stimulation by histamine. Synaptosomes from control and 
chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with histamine for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as describea in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) and two asterisks-(**) 
indicate that values from control and chloraecone exposed 
offspring are different at p<0.01 and p<0.001, respectively. 
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Figure 32. 32 P incorporation into phosphatidic acid 
of synaptbsomes from chlordecone exposed offspring: percent 
stimulation by histamine. Synaptosomes from control and 
chlordecone exposed off spring were preincubated with 
radiolabeled orthophosphate for 1 hour. The prelabeled 
synaptosomes were then stimulated with histamine for 30 
minutes. The reaction was terminated by adding 2 ml 
chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. The 
phospholipids were extracted as described in Materials and 
Methods. Each value represents the mean of 6 animals + the 
standard deviation. An asterisk (*) and two asterisks-(**) 
indicate that values from control and chlordecone exposed 
offspring are different at p<0.01 ana p<0.001, respectively. 
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prior to addition of histamine only slightly decreased the 
overall effects (Appendix I). Therefore, the amount of 
stimulation of the inositol phospholipids and phosphatidic 
acid due to histamine H receptor coupling is very small. 
Subsequently, there is very little H 1 receptor-coupled 
phospholipid turnover in the cortical region. 
Receptor-Coupled Phospholipid Turnover 
In summary, neurotransmitter stimulated phospholipid 
labeling increased with age, being maximal at 31 days of age 
in the order of TPI> PA> DPI> PI, and with decreasing 
effectiveness from 5HT> NA> CC> DA> HA. 
In chlordecone exposed offspring, neurotransmitter 
stimulation of phospholipid metabolism was significantly 
reduced in a dose- and age-dependent manner. The magnitude 
of the reductions was dependent on the neurotransmitter, 
but the overall stimulation pattern 
groups at all ages and exposures. 
antagonists atropine, haloperidol 
paralleled unexposed 
The incubation of the 
or regitine in the 
presence or 
noradrenaline, 
absence of carbamylcholine, 
respectively, resulted in 
dopamine 
little or 
or 
no 
stimulation. Bentazole 
slightly decreased the 
in conjunction with histamine only 
stimulation. Crossf ostering of 
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control and chlordecone exposed off spring did not produce 
significant differences from offspring which were not 
crossfostered. The inability of carbamylcholine to 
stimulate receptor-coupled inositol phospholipid turnover 
persisted 
brain. 
even after clearance of chlordecone from the 
Receptor Density and Affinity 
Muscarinic Receptor Binding 
Muscarinic receptor binding was examined in cortex and 
striaturr of noncrossfostered chlordecone exposed off spring 
at 17, 24 and 31 days of age (Table XVII). Muscarinic 
receptor concentrations and affinity, measured as a function 
of percent tritiated QNB binding, were in agreement with the 
regional distributions reported by Snyder et al. (1975). 
This work was done in Dr. Ron Ritzmann's laboratory at 
the University of Illinois. 
In 5, 15, and 30 mg/kg chlordecone exposed offspring, 
the cortical receptor concentrations were significantly 
reduced (p<0.001) at all ages and exposure levels (Figure 
33). Crossfostered offspring were also analyzed for 
receptor concentrations at 3 and 9 months of age in addition 
to the ages mentioned above. When chLordecone offspring 
were crossfostered postpartun., the receptor concentrations 
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Table XVII. Muscarinic receptor binding in cortex and 
striatum of chlordecone exposed offspring. Cortex and 
striatum from control and chlordecone exposed off spring were 
diluted to 0.66 mg tissue/ ml of buffer. The brain was 
homogenized and centrifuge6 for 10 minutes at 1000 x g. The 
supernatant was used for receptor binding studies as 
described in Materials and Methods. Tritiated QNB was used 
as the ligand and atropine as the displacer. Each value 
represents the mean of 6 animals + the standard deviation. 
An asterisk (*) and two asterisks (**) indicate that values 
from control and chlordecone exposed offspring were 
different at p<0.01 and p<0.001, respectively. 
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Table XVII 
MUSCARINIC RECEPTOR BINDING IN CORTEX AND STRIATUM 
OF CHLORDECONE EXPOSED OFFSPRING 
QNB Sites (pmol/ g protein) 
DAYS CORTEX STRIA TUM 
17 DAYS NONCROSSFOSTERED 
Control 310+14 349+19 
5 mg/kg 195+12** 220+11** 
15 mg/kg 124+6** 140+5** 
30 mg/kg 78+4** 94+3** 
CROSSFOSTERED 
Control 319+12 355+11 
5 mg/kg 199+6** 237+9** 
15 mg/kg 129+7** 149+3** 
30 mg/kg 88"+4** 9 9+4** 
24 DAYS NONCROSSFOSTERED 
Control 325+15 352+12 
5 mg/kg 184+11** 229"+10* 
15 mg/kg 118"+8** 142"+6** 
30 mg/kg 69"+3** 97"+3** 
CROSS FOSTERED 
Control 327+13 349+14 
5 mg/kg 203+14** 237+10* 
15 mg/kg 132"+7** 148"+4** 
30 mg/kg 83+2** 102"+6** 
31 DAYS NONCROSSFOSTERED 
Control 335+16 362+11 
5 mg/kg 199"+11** 239"+9** 
15 mg/kg 120"+9** 145"+6** 
30 mg/kg 81"+4** 101"+4** 
CROSS FOSTERED 
Control 330+13 359+13 
5 mg/kg 206+10* 253+11 * 
15 mg/kg 133+7** 157"+7** 
30 mg/kg 90"+3** 108"+5** 
3 MONTH CROSS FOSTERED 
Control 335+12 363+11 
15 mg/kg 172"+9** 182+7* 
9 MONTH CROSS FOSTERED 
Cor.trcl 327+14 367+12 
15 mg/kg 178+6** 227+10** 
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Figure 33. Muscarinic receptor binding in cortex of 
chlordecone exposed offspring. Cortex from control and 
chlordecone exposed offspring were diluted to 0.66 mg 
tissue/ ml of buffer. The brain was homogenized and 
centrifuged for 10 minutes at 1000 x g. The supernatant was 
used for receptor binding studies as described in Materials 
and Methods. Tritiated QNB was used as the ligand and 
atropine as the displacer. Each value represents the mean of 
6 animals + the standard deviation. An asterisk (*) and two 
asterisks(**) indicate that values from control and 
chlordecone exposed offspring were different at p<0.01 and 
p<0.001, respectively. 
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did not recover and were still significantly different from 
controls (p<0.001) at all ages and exposure levels except 24 
and 31 day old 5 mg/kg exposed offspring. In these offspring 
the concentrations were significantly different at the 
p<0.01 level. Even at 3 and 9 months of age, significant 
rehabilitation of muscarinic receptor content had not 
occurred. In both noncrossfostered and crossfostered 5, 15, 
and 30 mg/kg exposed offspring, absolute concentrations of 
muscarinic receptors were inversely proportional to exposure 
levels. 
Muscarinic receptor binding was also investigated in 
striatum of noncrossfostered and crossfostered offspring. 
Reductions in receptor concentration paralleled the results 
observed in cortical preparations (Figure 34). Receptor 
loss was dependent on concentration of chlordecone exposure. 
Even 3 or 9 months after cessation of dosing, significant 
reductions in receptor concentration were still seen. 
Muscarinic receptor affinity was calculated with a 
linear regression Scatchard analysis program. Although 
reference to reduction in receptor affinity utilizing this 
method only is not conclusive, it can be used as a basis 
for further investigation into possible effects on affinity 
of the ligand for the receptor. In both cortex and 
striatum, muscarinic receptor affinity was reduced (35%) at 
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Figure 34. Muscarinic receptor binding in striata of 
chlordecone exposed offspring. Striaturn from control and 
chlordecone exposed offspring were diluted to 0.66 mg 
tissue/ ml of buffer. The brain was homogenized and 
centrifuged for 10 minutes at 1000 x g. The supernatant was 
used for receptor binding studies as described in Materials 
and Methods. Tritiated QNB was used as the ligand and 
atropine as the displacer. Each value represents the mean of 
6 animals + the standard deviation. An asterisk (*) and two 
asterisks(**) indicate that values from control and 
chlordecone exposed offspring were different at p<0.01 and 
p<0.001, respectively. 
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all ages and exposure levels. But the magnitude of these 
reductions was comparable without regard to age or 
concentration of chlordecone exposure. 
Dopaminergic Receptor Binding 
Dopaminergic (D 2 ) receptor binding was examined in 
cortex and striatum of control and 15 mg/kg noncrossfostered 
chlordecone exposed offspring. The results observed 
paralleled noncrossfostered rnuscarinic receptor binding 
respect to reduction in receptor concentration (Figures 35 
and 36). The receptor concentration was decreased 
significantly at all ages (p<0.001) with respect to 
controls. Despite the changes seen in total receptor 
concentration, there was no significant difference in the 
receptor affinity for the ligand. 
Hypothalamic and Striatal Biogenic Amine Levels 
Biogenic amines concentrations from striatum and 
cortex were analyzed as described in Materials and Methods. 
The identification of individual biogenic amines was 
accomplished by reference between known quantities of 
standards (Figure 37) and tissue preparations (Figure 38). 
Striatal and hypothalamic biogenic amine levels of 
control offspring were consistent with quantities observeo 
by other invesigators for dopamine, DOPAC and noradrenaline 
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Figure 35. Dopaminergic receptor binding in cortex of 
chlordecone exposed offspring. Cortex from control and 
chlordecone exposed offspring were diluted to 0.66 mg 
tisEue/ ~l of buffer. The brain was homogenized and 
centrifuged for 10 minutes at 1000 x g. The supernatant was 
used for receptor binding studies as described in Materials 
and Methods. Tritiated spiperone was used as the ligand and 
butaclamol as the displacer. Each value represents the mean 
of 6 animals + the standard deviation. Two asterisks (**) 
indicate that-values from control and chlordecone exposed 
offspring were different at p<0.001. 
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Figure 36. Dopaminergic receptor binding in striatum of 
chlordecone exposed offspring. Striatum from control and 
chlordecone exposed offspring were diluted to 0.66 mg 
tissve/ ml of buffer. The brain was homogenized and 
centrifuged for 10 minutes at 1000 x g. The supernatant was 
used for receptor binding studies as described in Materials 
and Methods. Tritiated spiperone was used as the ligand and 
butaclamol as the displacer. Each value represents the mean 
of 6 animals+ the standard deviation. Two asterisks(**) 
indicate that values from control and chlordecone exposed 
offspring were different at p<0.001. 
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Figure 37. HPLC chromatogram of NA, DA, DOPAC, DHBA, 5HT 
and HIAA standards. 
< e 
E 
< 
< 
H 
I 
L'i 
170 
171 
Figure 38. HPLC chromatogram of NA, DA, DOPAC, DHBA, SHT 
and HIAA from a tissue sample. 
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(Hornykiewicz, 1966), and serotonin and HIAA (Brownstein et 
al., 1976). DOPAC and HIAA are the major metabolic products 
of dopamine and serotonin, respectively. 
Striatal Biogenic Amine Levels 
When offspring were exposed to 5 mg/kg chlordecone 
gestationally and lactationally, dopamine and DOPAC levels 
were significantly higher than control fed offspring (Figure 
39) at all ages. At a higher dosage of 15 mg/kg/day, 
dopamine and DOPAC levels were only significantly different 
in 31 day old animals. Increasing the dosage to 30 mg/kg 
elicited significantly different dopamine concentrations at 
24 and 31 days and DOPAC levels at all ages examined. 
Serotonin levels in striatum at most ages and exposure 
levels were not significantly different from controls 
(Figure 40). Serotonin levels of 17 day old offspring were 
significantly increased for 5 mg/kg and significantly 
decreased for 30 mg/kg chlordecone exposure levels. For 24 
day old animals, significant reduction in serotonin levels 
were observed for exposure levels of 15 and 30 mg/kg. At 31 
days of age, only 30 mg/kg chlordecone exposed animals had 
reduced serotonin levels. 
C~1anges ir: hydroxyindoleacetic acid (HIAi-.) le\'e~s die 
not parallel changes in serotonin levels (Figure 40). 
Significant increases were seen in 5 mg/kg exposed off spring 
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Figure 39. Striatal DA and DOPAC levels of chlordecone 
exposed offspring. Striatum from control and chlordecone 
exposed offspring were homogenized in 75% ethanol 20% (w/v). 
The internal standard DHBA was added to the homogenate to 
quantitate the percent recovery. The tissue was processed 
as described in Materials and Methods. Each value 
represents the mean of 3 animals + the standard deviation. 
Two asterisks (**) indicate that values from control and 
chlordecone exposed offspring were different at p<0.001. 
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Figure 40. Striatal 5-HT and HIAA levels of chlordecone 
exposed offspring. Striatum from control and chlordecone 
exposed offspring were homogenized in 75% ethanol 20% (w/v). 
The internal standard DHBA was added to the homogenate to 
quantitate the percent recovery. The tissue was processed 
as described in Materials and Methods. Each value 
represents the mean of 3 animals + the standard deviation. 
An asterisk (*) and two asterisks(**) indicate that values 
from control and chlordecone exposed offspring were 
different at p<0.01 and p<0.001, respectively. 
STRIATAL SEROTONIN AND HIAA LEUELS 
OF CHLORDECONE rxPOSID OFFSPRING 
1 77 
Control. - ::J 5mg/kg~15 mgfkg~::::eo mg/kg:-~ 
w 
::. ((I 
(l) 
...... 
I-
•:!:I 
·~ ::::: 
w 
' (1-.1 
((1 
...... 
I-
'P 
•:.D 
:;::: 
z500 
Zl:HiC 
1500 
10 a a 
500 
a 
!.COO 
?SO 
SOD 
zsc 
a 
SEROTONIN 
1 ~ j' -· .• 
....... I ·~/ ::. 
HIAA 
AGE 
178 
at all ages examined. In 30 mg/kg exposed offspring, 
significant decreases in HIAA were observed. For 15 mg/kg 
chlordecone exposed offspring, significant differences were 
observed in 31 day old animals only. 
Striatal noradrenaline displayed an exposure- and 
age-dependent decrease (Figure 41). Levels decreased as 
the age increased and these reductions were inversely 
proportional to the exposure levels. Noradrenaline 
concentrations were significantly different from controls 
at all ages and exposure levels. The magnitude of these 
differences was p<0.01 for 17 and 31 day old 5 mg/kg 
offspring and p< 0.001 for all other groups. 
Hypothalamic Biogenic Amine Levels 
Serotonin levels in the hypothalamus were 
significantly different from those of controls except in 24 
day 
and 
from 
old 15 mg/kg exposed offspring (Figure 42). 
30 mg/kg exposed animals were significantly 
control at the 0.001 level but the former 
Both 5 
different 
displayed 
significant increases while the latter showed decreases. 
Serotonin levels of 15 mg/kg chlordecone exposed offspring 
showed a significant increase from 17 to 24 days of age but 
that increase was ne92ted by 31 days of age. 
Hypothalamic HIAA levels paralleled striatal levels 
in relative differences between exposed groups and controls 
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Figure 41. Striatal noradrenaline levels of chlordecone 
exposed offspring. Striatum from control ana chlordecone 
exposed offspring were homogenized in 75% ethanol 20% (w/v). 
The intern2l standard DHEA was added to the homogenate to 
quantitate the percent recovery. The tissue was processed 
as described in Materials and Methods. Each value 
represents the mean of 3 animals + the standard deviation. 
An asterisk (*) and two asterisks T**) indicate that values 
from control and chlordecone exposed off spring were 
different at p<0.01 and p<0.001, respectively. 
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Figure 42. 
chlordecone 
chlordecone 
ethanol 20% 
Hypothalamic serotonin and HIAA levels 
exposed offspring. Hypothalamic from control 
exposed offspring were homogenized in 
(w/v). The internal standard DHBA was added 
of 
and 
75% 
to 
the ho~ogena~e ~c ~~an~itate the percent recovery. T~c 
tissue was processed as described in Materials and Methods. 
Each value represents the mean of 3 animals + the standard 
deviation. An asterisk (*) and two asterisks (**) indicate 
that values from control and chlordecone exposed offspring 
were differen·t at p<0.01 and p<0.001, respectively. 
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HVPOTHALAMIC SEROTONIN AHD HIAR LEVELS 
OF CHLORDECOHE EXPOSED OFFSPRING 
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(Figure 42). There were significant increases in 5 mg/kg 
exposed offspring at all ages. Significant differences also 
were seen in 30 mg/kg animals but the differences were less 
significant at 24 and 31 days of age than at 17 days old. 
In offspring exposed to 15 mg/kg/day, significant 
differences were only observed at 17 days of age. 
Noradrenaline levels in the hypothalamus were 
increased significantly in all-5 mg/kg and decreased in all 
30 mg/kg animals at all ages examined (Figure 43). Only 31 
day old 15 mg/kg chlordecone exposed offspring displayed 
significantly different noradrenaline levels compare~ tc 
control fed offspring. 
Dopamine levels in the hypothalamus significantly 
increased with age in 5 mg/kg exposed animals (Figure 44). 
For 15 and 30 mg/kg exposed offspring, significant 
differences were observed at 24 and 31 days of age. But the 
level of difference was greater for 30 mg/kg (p<0.001) than 
for 15 mg/kg animals (p<0.01). 
Signif icar.t increases in DOPAC levels were seen in 24 
day old 15 mg/kg and all ages of 5 mg/kg chlordecone exposed 
offspring (Figure 44). In 30 mg/kg exposed animals, 
sign{ficant reductions in DOPAC levels were observed at 24 
and 31 days of age but not at 17 days. 
184 
Figure 43. Hypothalamic noradrenaline levels of chlordecone 
exposed offspring. Hypothalamus from control and chlordecone 
exposed offspring was homogenized in 75% ethanol 20% (w/v). 
The internal standard DHBA was added to the homogenate to 
qua~titate the perce~t recovery. The tissue was processe~ 
as described in Materials and Methods. Each value 
represents the mean of 3 animals + the standard deviation. 
Two asterisks (**) indicate that-values from control and 
chlordecone exposed offspring were different at p<0.001. 
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Figure 44. Hypothalamic DA and DOPAC levels of chlordecone 
exposed offspring. Hypothalamus from control and chlordecone 
exposed offspring was homogenized in 75% ethanol 20% (w/v). 
The internal standard DHBA was added to the homogenate to 
qua~titate the percen~ recovery. The tissue was processed 
as described in Materials and Methods. Each value 
represents the mean of 3 animals + the standard deviation. 
An asterisk (*) and two asterisks(**) indicate that values 
from control and chlordecone exposed off spring were 
different at p<0.01 and p<0.001, respectively. 
HYPOTHALAMIC DOPAMINE AND DOPAC LEUELS 
OF CHLORDECONE EXPOSED OFFSPRING 
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Brain Biogenic Amine Levels 
In summary, striatal and hypothalamic biogenic amines 
increased significantly compared to controls in all ages of 
5 mg/kg chlordecone exposed offspring. Conversely, 30 mg/kg 
exposed offspring also displayed significantly different 
results but those differences were manifested in absolute 
reductions in biogenic amine levels. The effects on brain 
biogenic amines from exposure to 15 mg/kg/day chlordecone 
were dependent on the amine or its metabolite examined. 
CHAPTER V 
DISCUSSION 
The objective of this research was to examine the 
effects of maternal chlordecone exposure on receptor-
mediated events in developing rat brain. It was proposed 
that CNS development in the presence of a lipophilic 
chlorinated insecticide such as chlordecone results in a 
significant change in the extent of 
stimulated synaptic membrane events. 
Biochemical Chanoes During Development 
neurotransmitter-
During growth and development of the brain, there are 
many changes at the cellular and molecular levels. There is 
a rapid decline in the rate of protein synthesis soon after 
birth with a more gradual decline thereafter (Schain et~., 
1967). The average half-life of proteins in the rat brain 
progressively increases with the age of the animal due to an 
increased synthesis of protein with longer turnover rates 
(Lajtha et ~., 1957). Total protein concentration 
increases progressively in the cortex and white matter until 
about 30 days of age in the rat. A decrease in protein 
concentrations after 30 days of age is due to the 
accumulation of myelin lipids. 
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Total brain lipids increase in content during 
development (Sperry, 1962). Brain lipids consist of 
cholesterol, phospholipids, and glycolipids. Brain 
cholesterol and phospholipid content increases during early 
postnatal development, which parallels the development of 
membranes (Davison and Dabbing, 1968). 
Gangliosides and 
containing lipids and 
located in synaptic 
glycoproteins are carbohydrate-
proteins, respectively, that are 
membranes. Gangliosides and 
glycoproteins 
recognition, 
are known to be involved in cell-cell 
contact and adhesion processes, and as 
components of several receptors for neurotransmitters. 
Gangliosides are most abundant within the grey matter 
where they are found in neuronal membranes, although little 
is known about the distribution of individual ganglioside 
species within these membranes. Gangliosides increase in 
content and concentration during brain development (Suzuki, 
1965). During the first ten days of normal postnatal brain 
6evelopment in th~ ra~, ganglioside content per cell greatly 
increases. In the normal rat cortex, gangliosi6e content 
peaks at about 20 days of age (Bass et~., 1969). This 
increase is correlated with the growth of dendritic 
processes and the formation of synaptic junctional 
complexes. Most of the evidence that the developmental peak 
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in ganglioside concentration correlates with the formation 
of synapses has been obtained f rorn observations that 
polysialogangliosides have been found to be particularly 
rich within the synaptic cleft region (Wiegandt, 1967). 
Synaptic membranes are particularly rich in gangliosides 
(Tettamanti, 1971). 
De Silva et ~· (1979) demonstrated developmentally 
related alteration of rat brain synaptic membrane 
glycoproteins. They demonstrated a 2-3 fold increase in 
synaptic membrane glycoprotein sialic acid between 5 and 60 
days of ace. Recently, Fu et al. (1981) also reported 
changes in the synthesis of synaptic membrane and synaptic 
junctional membrane fucosyl- and sialylglycoproteins with 
postnatal age. In addition to age-dependent changes in 
glycoprotein synthesis, there appear to be environmental 
influences on glycoprotein synthesis. Burgoyne and Rose 
(1980) observed altered incorporation of tritiated fucose 
and lysine in the visual cortex of dark-reared rats upon 
first exposure to light. Studies by Sukumar et al. (1980) 
on learning and memory provided additional support for 
environmerita 11 y related alterations of glycoprotein 
synthesis. 
Therefore, the development of the brain involves the 
interaction of many membrane constituents. The tindings 
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discussed above demonstrate that synaptic plasma membranes 
are composed of many complex components which collectively 
control intra- and extramembrane processes. Therefore, 
these components could individually or collectively affect 
the cellular and molecular processes involved in the 
parameters examined in this study. In view of tne fact that 
the effects of chlordecone on selected membrane components 
or associated events have not been previously examined 
except 
endless 
starting 
effects 
in the case of sodium-potassium ATPases, there were 
processes that could have been selected as a 
point. In an attempt to elucidate the possible 
of chlordecone on the developing membrane system, 
this study examined a neurotransmitter-stimulated membrane 
event as opposed to the parameters discussed above. 
Maternal Weight Gain and Diet Consumption 
Based on consumption of diet both during and after 
gestation, control and chlordecone fed mothers received a 
comparable amount of protein and calories. The average 
weights of the mothers were comparable during the first week 
of liquid diet consumption. By the third week, the relative 
weight gains for 5, 15 and 30 mg/kg exposed mothers were 86, 
82 and 77% of control. Chernoff and Rogers (1976) observec 
similar reductions in maternal body weights in chlordecone 
exposed animals. They suggested that these differences were 
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due to the reduced size of the litters. But in the present 
studies, these weight reductions persisted three weeks after 
birth of the off spring in both chlordecone and control fed 
(chlordecone exposed during gestation) mothers. The ref ore 
these differences were not due to variable diet consumption, 
litter size or continuous chlordecone consumption. 
Consequently, these differences could be related to the 
interaction of an unforeseen nutritional parameter with 
chlordecone such as absorption and/or utilization of 
nutrients. 
Brain and Body Weights of Offspring 
Brain and body weights of off spring reflect the 
different consumption of chlordecone by mothers fed the 5, 
15 or 30 mg/kg diet. In general, brain and body weights of 
5, 15 and 30 mg/kg exposed offsrring were significantly 
lower than those of age-matched control pups. The brain and 
body weights were inversely proportional to the 
concentration cf exposure. The normal body and brain 
weights of age- and diet-matched control and chlordecone 
exposed offspring in these studies are consistent with 
previous studies (Chernoff and Rogers, 1976; Seth et~., 
1961; Et 
et ~. , 1 9 8 2 ) . 
- , 
~·t 1 9 7 9 ; Mac tutu s et ~ . , 19 8 2 ; Ti 1 so;, 
However, the above studies mentioned did 
not utilize as carefully planned exposure schedules as 
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described here. This is the first study to demonstrate 
linear dose-dependent body and brain weight reduction in 
offspring following in utero chlordecone exposure. In 
addition, results presented in this study dispel the notion 
that these effects were due to maternal malnutrition alone. 
Crossfostered offspring still displayed reduced body and 
brain weights even 31 days after cessation of the 
chlordecone diet. Therefore, any abnormalities found in the 
present study are due to effects of chlordecone on the 
prenatal development of in utero exposed offspring. 
Brain Chlordecone Levels 
Fujimori et~· (1982) demonstrated that afte~ a single 
dose of chlordecone, brain levels were proportional to the 
amount given and that these levels reached a maximum 
concentration at 6 hours after treatment. The chlordecone 
concentrations remained at that level up to 96 hours after 
administration. In agreement with these findings, End et 
al. (1978) reported that the half-life of chlordecone in the 
brain was in excess of 17 days. 
Other studies have not attempted to investigate the 
effects of ffiaternal consumption of chlordecone on brain 
concentrations of chlordecone in the offspring. This study 
has demonstrate6 that chlordecone levels in cerebral 
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hemispheres of gestationally and lactationally exposed 
offspring were directly proportional to the exposure 
levels. This level reached a maximum concentration by 17 
days of age and maintained that level through at least 31 
days. Therefore, the maximum brain levels of chlordecone 
were probably reached before 17 days of age as partially 
attested to in single dosed animals. A significant finding 
of these studies was that it appears that crossfostering of 
5, 15 and 30 mg/kg exposed offspring postpartum with control 
mothers did not significantly reduce the brain chlordecone 
levels even 31 days after cessation of exposure. It was not 
until 3 months after cessation that the chlordecone levels 
were reduced to 3 ug/g tissue and 9 months until the levels 
were undetectable. Therefore, these studies show that after 
chronic dosing of chlordecone, it takes at least 3 months 
before chlordecone is cleared from the brain. This extends 
the knowledge from prior studies in which Egle et al. (1978) 
demonstrated that clearance of chlordecone from rat brain 
after a single bolus required at least 8 weeks. 
Therefore, these studies have demonstrated that brain 
chlordecone levels (1) are proportional to exposure levels, 
(2) are maximum by 17 days of age and are maintained through 
31 days of age, whether the exposure was throughout 
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gestation and lactation or during gestation alone, and 
(3) persist at least 3 months after cessation of dosing. 
Membrane Protein and Phospholipid Concentrations 
Synaptic plasma membrane protein concentrations of 17, 
24 and 31 day old pups were in agreement with levels seen by 
Smith (1983). There are no apparent changes in total 
membrane protein concentrations at any of the ages or 
exposure levels examined. 
Similar results were observed in synaptic plasma 
membrane phospholipid concentrations as were observed with 
protein concentrations. Phospholipid distribution was not 
affected at any of the exposure levels or ages examined. 
The distribution of phospholipids from 17, 24 and 31 day old 
pups was in agreement with levels seen by Fontaine (1980). 
However, the results do not rule out the possibility 
that the exposure of developing membrane to varying doses of 
chlordecone affects the protein and phospholipid composition 
of those membranes. Any effects observed that involve 
these membranes could be due to one or more of the following 
factors: (1) the preparation used for isolation of synaptic 
plasma membranes could have selected for membranes of normal 
density and hence, protein yield and phospholipid 
composition; (2) the yield of the synaptic plasma membranes 
was so low that the changes in protein or phospholipid 
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concentration and distribution were undetectable; or (3) the 
effects of in utero chlordecone exposure were manifested in 
the alteration of other membrane constituents such ·as 
gangliosides and glycoproteins. 
Phospholipid Stimulation 
Hokin and Hokin (1958) were the first to show the 
neurotransmitter-stimulated phospholipid turnover with 
acetylcholine {ACh) in guinea pig cortex slices. 
Sympathetic ganglia, known to be rich in synapses, also 
showed a similar effect in response to ACh {Hokin et ~., 
1960), electrical stimulation (Larrabee et al., 1963) or 
potassium ions (Nagata et~., 1973). Since then a number 
of investigators have demonstrated that cholinergic and 
adrenergic neurotransmitters stimulate the incorporation of 
radiolabeled orthophosphate into phospholipids of neural 
tissue both in vivo (Friedel and Schanberg, 1973; Friedel et 
~., 1973; Margolis and Heller, 1963) and in vitro (Abdel-
Latif et ~., 1974; Hokin, 1969). It is now well 
established that the neurotransmitter effects occur chiefly 
in phosphatidic acid and the inositol phospholipids and 
require exterr,a 1 ca 1 ci urr, a con di ti on al so necessary for 
transmitter release (De Belleroche and Bradford, 1972). The 
physiological significance o~ the neurotransrritter effect is 
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not clear, but available evidence suggests that it is 
related to the binding of the neurotransmitter to its 
respective receptor and subsequent activation of a stimulus-
response cascade (Garnbetti et al., 1974; Hawthorne and 
Bleasdale, 1975). 
Reddy and Sastry (1979). proposed that this phenomenon 
is related to an aspect of synaptic function that could 
serve as a measure of synaptic density or synaptogenesis in 
developing brain. If this hypothesis is true, a progressive 
increase in the magnitude of the neurotransmitter effect 
he )j '- c~~2rve~ ~it~ increase in age in thE develoring 
brain. Furthermore, a study of the neurotransmitter effect 
in chlordecone-exposed off spring affords a means of 
assessing nutritional damage to synaptogenesis or synaptic 
ultrastructure and function. For this purpose, however, it 
was necessary to have suitable brain preparations that give 
reproducible neurotransmitter effects. Experiments with 
brain slices are highly variable (Hokin and Hokin, 1956; 
Hokin, 1969) and the stimulatory effect is dependent on the 
thickness of the slices (Abdel-Latif et~., 1974). On the 
other hand, the neurotransmitter effect is not usually 
observed with brain homogenates. Even with particulate 
fractions, Redman and Hokin (1964) obtained highly variable 
stimulatior.. 
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The experiments reported here show that purified 
synaptosomal preparations exhibit highly reproducible 
neurotransmitter effects. The results for control animals 
were in agreement with the magnitude of stimulation seen by 
Reddy and Sastry (1979) in similarly aged animals. The 
neurotransmitter effects with these preparations were mainly 
associated with phosphatidic acid and inositol 
phospholipids, and maximal stimulation was observed with 1 
mM carbamylcholine and 10 mM noradrenaline or serotonin. 
These concentrations, though apparently high, are probably 
in a physiological range. Earlier workers (Abdel-Latif, 
1974; Hokin and Hokin, 1955; Lapetina and Michell, 1972) 
have used 10 mM carbamylcholine, noradrenaline and serotonin 
in experiments with slices. In fact, Hokin (1969) estimated 
the levels of biogenic amines to be around 100 m.M in 
synaptic vesicles. 
The incubation of the receptor antagonists atropine, 
haloperidol or regitine in the presence or absence of 
carbamylcholine, dopamine or noradrenaline, respectively, 
resulted in little or no stimulation. Bentazole ir; 
conjuction with histamine only slightly decreased the 
stimulation. These results suggest that the stimulation of 
phosphoiipia 
stimulation 
turnover ano resultant inhibition of 
seen in control and chlordecone exposed 
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offspring, respectively, are due to a receptor mediated 
event. 
neurotransmitter effect on Experiments 
synaptosomes from 
on the 
cortical regions of developing rats 
demonstrated that there was a progressive increase in 
synapses during the weanling period {birth to weaning), as 
observed by Reddy and Sastry (1979). Therefore, the 
relative magnitude of stimulation for phosphatic acid and 
the phosphatidylinositols increased with age within an 
exposure group. These experiments verify the previous 
res~lts ty Reddy and Sast~y (1979) that the neurotransmitter 
effect is a valid biochemical correlate of synaptogenesis in 
developing brain. 
The neurotransmitter effect determined under 
comparable conditions in chlordecone-exposed offspring was 
significantly different froffi normal brains. In chlordecone 
exposed offsprin9, neurotransmitter stirulaticn o~ 
phospholipid metabolism was significantly reduced in a dose-
and exposure time-dependent manner. The magnitude of the 
reduction was dependent on the neurotransmitter, but the 
overall stimulation pattern paralleled unexposed groups at 
all ages and exposures. 
These results suggest that exposure to chlordecone 
prenatally may affect processes involved ~ith synaptcgenesis 
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during the weanling period. This hypothesis is supported by 
studies done on the effects of malnourishment (Reddy and 
Sastry, 1978; Balazs and Patel, 1973), DDT and related 
chlorinated hydrocarbon insecticides (Hrdina et al., 1975), 
and estrogen (Arai and Matsumoto, 1978). These 
investigators demonstrated that exposure to these factors 
during the vulnerable period of growth impairs brain 
maturation and might lead to an irreversible deficit in 
higher mental function. Morphologically these studies have 
shown that migration of cells is retarded, proliferation of 
neuronal fibres decreased and formation of synapses and 
myelin reduced. Reddy and Sastry (1978) also demonstrated 
that gangliosides but not phospholipids were significantly 
reduced in undernourished rats. With the knowledge that 
gangliosides are particularly rich in synaptic membranes and 
that these lipid components may be directly involved in 
me~brane phenomena, their metabolism in chlordecone-exposed 
offspring could contribute either directly or indirectly to 
the reduction in the magnitude of the 'pr effect' observe6. 
Mechanism of Phospholipid Turnover 
One possible mechanism of chlordecone neurotoxicity 
has been suggested that inhibitio~ of mitochondrial anc 
synaptosomal membrane bound sodium-, potassium- ATPases 
(Desaiah, 1981). These observations could possibly account 
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for the decreased turnover due to the lack of energy needed 
to drive the subsequent resynthesis after initial 
phospholipid breakdown. However, Abdel-Latif et al. (1968) 
demonstrated that addition of metabolic inhibitors to ATP 
formation did not inhibit the phosphorylation of 
phosphatidic acid and inositol phospholipids. Thus the 
small residual ATP-generating capacity was sufficient to 
drive the biosynthesis of phospholipids after 
neurotransmitter stimulated breakdown. 
The results presented in this study demonstrate that 
the extent of phospholipid turnover was dependent on the 
concentration of chlordecone the off spring received and the 
cumulative dose to which the offspring were exposed. 
Therefore, a pup from a mother given 15 mg/kg/day 
chlordecone during gestation and lactation or gestation 
alone displayed significant differences in phospholipid 
turnover at 17 days of age compared to control, but those 
differences were even greater at 31 days of age. Other 
investigators (Cohn et 91_., 1978; Taylor et al., 1978) 
suggested that chlordecone disrupted membrane processes by 
being present in the membrane and that decreasing 
concentratioDs resulted in decreased effects. These 
investigators also speculated that when the chlordecone was 
removed from the brain, the "neurotoxicity" associated with 
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the presence of chlordecone would be reversed. The present 
study contradicts this assumption, in that by 3 and 9 months 
after cessation of dosing, the brain chlordecone 
concentrations are either low {3 ug/g tissue) or not 
detectable. Nevertheless, neurotransmitter-stimulated 
phospholipid labeling was suppressed to nearly the same 
extent in these offspring as in 31 day old offspring having 
cerebral chlordecone levels of 30-40 ug/g. 
Chang-Tsui and Ho (1980) suggested that one of the 
actions of chlordecone in the central nervous system is on 
neurotransmitter and receptor interaction. This would seem 
a likely hypothesis according to the data that have been 
generated by other investigators. Phospholipid metabolism 
changes are involved in actions consequent to agonist-
receptor interactions in many physiologically important 
systems. In particular, activation of m;]scarinic 
cholinergic receptors has been implicated in enhanced 
phospholipid turnover in a number of tissues (Michell, 1975; 
Hawthorne and Pickard, 1979; Berridge, 1981). This study 
has sought to utilize this phenomenon to discern whether the 
reduced phospholipid turnover may be due, in part, to the 
inability of the a9onist to stimulate this recep-:.or 
coupling. This loss of receptor-coupled stimulation could 
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be due to reduced receptor concentrations or receptor 
binding affinity. 
Receptor Density and Affinity 
Synaptic transmission provides a basis for 
intercellular communication in the nervous system. For many 
years, it has been suggested that synaptic transmission is a 
regulated process (Muknerjee et~., 1980). On a molecular 
basis, modulation of synaptic transmission could likely 
occur through regulation of neuroreceptor concentration 
(Schaeffer and Hsueh, 1980). The most widely used standard 
method for the identification of cell-surface receptors 
involves studies on the binding of specific radioactive 
ligands in the presence or absence of competitors in order 
to determine the extent of specific and nonspecific binding 
in preparations of the tissue being examined. 
In the present study, sufficient chlordecone was 
administered to elicit mild to severe tremors in 5 to 30 
mg/kg chlordecone exposed offspring but no lethality was 
observed at these dose levels. Several studies have 
suggested that neurons associated with central 
catecholamines are affected by chlordecone. Decreases in 
tritiated spiroperidol binding to striatai membrane 
preparations were observed in rats fed as little as 10 pplli 
chlordecone (Seth et~., 1981). This study also observed 
205 
chlordecone-dependent reductions in receptor binding but 
additionally demonstrated that these reductions were 
dependent on the exposure level of chlordecone and the age 
of the offspring. Seth et al. (1981) also observed 
decreased cerebellar tritiated QNB binding but discounted 
that the reductions were due to increases in non-receptor 
interfering proteins rather than alterations in binding 
sites. This study contradicts the above findings and has 
shown that muscarinic receptor concentrations are 
significantly reduced at all ages and exposure levels. 
The decreases ir recertor concentrations were 
independent and exposure-dependent. Crossfostered offspring 
were examined for effects on receptor concentra~ions. These 
studies confirmed the results seen with noncrossfostered 
animals in that the reduction was age-independent and 
depender.t the leve: of in utero chlordecone exposure. 
Even 9 months after cessation of dosing and clearance of the 
brain chlordecone levels, significant reduction in 
rnuscarinic receptor binding was still observed. Therefore, 
the rnuscarinic receptor binding studies support the 
hypothesis that chlordecone may be developmentally 
neurotoxic. 
The causes of this developmental neurotoxicity are 
only speculative, but the most plausible explanation for 
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the decreased inositol phospholipid stimulation and receptor 
concentration and affinity involves direct or indirect 
effects on the receptor complex and/or reduced numbers of 
synapses. One possible mechanism is that chlordecone may 
alter neuronal connectivity; chlordecone may induce a 
permanent structural modification of synaptic terminals by 
acting as an estrogenic agent (discussed later). 
These effects could be manifested in the inhibition of 
synthesis of 
Lapetina et 
a necessary membrane or 
al. (1967) elucidated 
receptor component. 
that ganglioside-rich 
nerve endinas contain acetylcholine, serotonin, 
noradrenaline, dopamine and histamine. The highest 
concentrations of these neurotransmitters were observed in 
cholinergic synaptic membranes. These investigators also 
demonstrated that within these gangliosiae-rich nerve 
endings, (Na -K )-activated ATPase, adenylate cyclase, and 
the particulate phosphodiesterase were also concentrated. 
Little is known about the production or structure of the 
components of bioge~ic amine receptors. 
Neurotransmitter Levels 
The data collected from previous experiments regarding 
neLlrotransmitter levels in animals exposed to chlordecone 
are varied and contradictory. Aldous et al. (1984) observed 
no alterations in steady state levels of noradrenaline (~A) 
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and dopamine (DA), nor of their metabolites, MOPEG and 
DOPAC, 24 hours after a single dose of 25, 50 or 100 mg/kg. 
These findings were consistent with those of other 
investigators using moderate doses of chlordecone. End et 
al. (1981) found similar results in mouse brain NA or DA at 
24 hours after administration of 40 mg/kg chlordecone. 
Negative findings by End et~· (1981) suggest that if 
alterations in brain catecholamine synthesis do occur, they 
are not of significant magnitude and are in the direction of 
reduced synthesis. 
Earlier observation that ~hlordecone is a potent 
inhibitor of ATPases associated with uptake and storage of 
catecholamines (Desaiah et al., 1980; Desaiah and Koch, 
1975; Chang-Tsui and Ho, 1980) led to anticipation that 
brain neurotransmitter levels and synthesis might be 
aprreciably a~fected. 
Rosecrans et al. (1982) observed that chlordecone 
affected indoleamine containing neurons. In each brain area 
evaluated, chlordecone-treated rats exhibited a higher rate 
of turnover of serotonin (5-HT), at least when measured by 
either 5-HIAJI. or 5-HIAA/5-HT ratio. Squibb and Tilson 
(1982) indicated that high doses of chlordecone increased 5-
HT turnover in the adult rat, which provides additional 
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evidence that this neurotoxicant has effects on this 
biogenic amine. 
Fujimori et al. (1982) reported decreases in mouse 
striatal DA after 9 days dosing with 25 mg/kg. They also 
found a decrease in mouse brain DA after 2 days 
administration of 50 mg/kg/day, a tremorigenic dose of 
chlordecone. Chang-Tsui and Ho (1980) reported the effects 
of chlordecone on synaptosomal uptake of DA. Both in vitro 
and in vivo effects of chlordecone on DA uptake into mouse 
brain synaptosomal fractions were shown to be inhibitory and 
concentration- and age-dependent. 
The results from the studies here are consistent 
with the results discussed above but also carry the 
experiments a step further. All of the experiments 
discussed above involved acute or chronic dosing of adult 
animals. This study provides evidence for the neurotoxic 
or teratogenic effects of chlordecone on off spring exposed 
pre- and postnatally. In both brain areas examined, DA, 5-
HT and their respective metabolites were significantly 
increased compared to control for 5 mg/kg exposed off spring 
at all ages. Conversely, all biogenic amine levels were 
significantly decreased at all ages in 30 mg/kg expose~ 
offspring. Biogenic amine levels in offspring from mothers 
giver. 15 sg/kg/day chlordecone did not follow a . ~. SpECl~lC 
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pattern but were dependent on the biogenic amine, age and 
brain area examined. 
The data presented suggest the possible involvement of 
DA and 5-HT in chlordecone-induced neurotoxicity. It has 
been proposed that a relationship exists between DA and 5-HT 
in the caudate (Goldstein et~., 1971). Makseed and Baker 
(1973) have suggested that 5-HT plays a modulatory role in 
the caudate in the expression of tremor and that its action 
is antagonized by DA. The present study has shown that 
31 there were reduced dopamine receptor concentrations in 
day old offspring from mothers exposed to 15 mg/kg/day and 
that the reduced receptor concentrations did not result in 
increased dopamine concentrations. 
Effects of Chlcrdecone on Developing Rat Brain 
A plausible mechanism by which the presence of 
chloraecone coula perffianer.tly alter brain function involves 
chlordecone acting as an estrogenic agent during the 
perinatal "critical period." The term "critical period" 
irnplies a 
differentiation 
specific 
when the 
period during developmental 
brain can or will respond to 
steroid exposure with permanent changes (Tarttelin et ~., 
19 7 5). There~ore, t~e critical period is the time durins 
which organizational actions of the gonadal steroids are 
expressed. In the rat, the upper limit of this period is 
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generally considered to be contained within the first ten 
days of life. However, the sensitivity to steroids is much 
greater during the first half of the time period 
(Christensen and Gorski, 1978). Several investigators have 
demonstrated that high concentrations of gonadal hormones, 
specifically estrogen, during the perinatal critical period 
inhibit synaptogenesis (Gordon et al., 1977; Nomura et~., 
1982; Gurney, 1981; Raisman and Field, 1973). It has been 
shown by several investigators that chlordecone acts as a 
weak estrogenic agent (Chernoff and Rogers, 1976; McFarland 
and Lacy, 1969). Therefore, high concentrations of 
chlordecone during the critical period of synaptogenesis 
could affect the developmental processes responsible for 
neurotransmitter-stimulatea phospholipid turnover, receptor 
concentration, and synthesis and turnover of biogenic amines 
by exerting an "estrogenic" effect. Thereby, the results of 
this "estrogenic" effect are not only the loss of dendritic 
processes and synapses during early development but a long-
term neurotoxic effect in the absence of chlordecone. 
CHAPTER VI 
CONCLUSIONS 
It was proposed that CNS development in the presence 
of a lipophilic chlorinated insecticide such as chlordecone 
results in a significant change in the extent of 
neurotransmitter-stimulated membrane events. Therefore, the 
objective of the research described in this dissertation was 
to examine specific biochemical constituents and events such 
as receptors, biogenic amines and phospholipid labeling in 
central nervou8 sys tell' (CNS) cortical regions and 
synaptosomes during early development. Offspring of 
Sprague-Dawley rats were pair-fed a chlordecone-containing 
diet on a chronic basis throughout gestation and lactation 
or during gestation alone. 
The present series of experiments provides new and 
exc i tins inf orr.12 ti o:-· concerning the effects of pre- and 
postnatally administered chlordecone on a neurotransmitter-
stimulated membrane event throughout early adulthood. This 
is the first time so many interrelated biochemical 
parameters have been measured and correlated in chlordecone 
exposure ranges of this magnitude and duration. ThE 
bioche~ical anc neurochemical evaluations of the off sprins 
have reveale6 five separate findings: (1) body and brai~ 
21] 
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weights were reduced by chlordecone in a dose-dependent 
manner; (2) protein and phospholipid concentrations and 
distributions were not dependent on dose or age; (3) 
neurotransmitter stimulation of phospholipid turnover was 
significantly reduced in a dose- and age-dependent manner; 
(4) muscarinic and dopaminergic receptor binding were also 
reduced in the same manner; (5) biogenic amine levels in 
hypothalamic and striatal tissue were significantly 
increased in off spring exposed to 5 mg/kg chlordecone and 
significantly reduced in 30 mg/kg exposed offspring. 
In all well designed experiments involving the 
measurement of several dependent variables, one is tempted 
to speculate on the relationships among all of these 
variables. The above results could indicate any or all of 
the following speculative explanations. 
Brain and body weights, phospholipid turnover ana 
receptor binding of exposed off spring could be reduced due 
to the interaction during the critical period between 
chlordecone and a developmentally necessary process such as 
membrane/receptor production. As the dosage of chlordecone 
exposure is increased, there is a severe infringeDent on 
this process or related processes that cause even greater 
reductions ir. these parameters. This may involve the 
inhibition of the production of membrane/receptor 
213 
constituents--for example, gangliosides or glycoproteins, 
as discussed. 
If the membrane/receptor environment alone is 
disturbed by the presence of chlordecone, as in the case of 
noncrossfostered and crossf osterea off spring up to 31 days 
of age, then this could serve as a possible explanation for 
the reduced phospholipid labeling and receptor binding seen 
at those ages. But this could not explain the persistent 
decreases in phospholipid labeling and muscarinic binding 
seen in 9 month old off spring in the absence of 
chlordecone, nor the lack of in vitro effects of 
chlordecone on these processes. Therefore, there might be 
a disturbance in the membrane/receptor environment by the 
presence of chlordecone but the effects of that disturbance 
are not significant enough to cause long-term neurotoxic 
effects. 
Therefore, although significant differences have been 
demonstrated between pre and postnatally exposed control and 
chlordecone offspring, it is very difficult to pinpoint the 
mechanism by which these effects are manifested. One 
possible mechanism is that chlordecone could permanently 
alter brain function by acting as an estrogenic agent 
during the perinatal "critical period." The presence of 
cor:centra ti OLS of c!-:lordecone in developing br2in 
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may alter neuronal conductivity and induce permanent 
structural modification of synaptic terminals. 
In view of the promising directions and conclusions 
of these experiments as to the possible involvement of 
chlordecone with specific biochemical events in utero, 
further studies are necessary to elucidate the mechanisms 
involved in chlordecone induced neurotoxicity. 
To investigate the possibility that chlordecone is 
acting as an estrogenic agent, the following experiments 
could be performed. An estrogenic agent such as 
diethylstilbesterol (DES) could be given to mothers, and the 
effects on neurotransmitter-stimulated phospholipid 
turnover, receptor binding and biogenic amine levels could 
be examined. DES has a longer biological half-life than 
other estrogenic compounds such as estradiol so that the 
concentrations in utero would be similar to the 
concentrationE of chlordecone. To determine whether 
chlordecone exerts its effects during the "critical 
period," chloraecone co;;ld be administered during the first 
10 days of life. In addition to examining the biochemica! 
processes discussed in this dissertation, other parameters 
such as synaptic plasma membrane constituents, synaptic cell 
size and number, 
investigated. 
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and neuronal connectivity could be 
Therefore, the work presented in this dissertation has 
demonstrated that chlordecone causes significant changes in 
membrane-associated events, and these results have opened to 
new avenues to explore as to the possible mechanism of 
chlordecone's actions. 
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Appendix A. Carbamylcholine stimulated radiolabeled 
orthophosphate incorporation into inositol phospholipids and 
phosphatidic acid of synaptosornes from chlordecone exposed 
offspring. Synaptosomes from control and chlordecone 
exposed offspring were preincubated with radiolabeled 
orthophosphate for 1 hour. The prelabeled synaptosomes were 
then stimulated with carbarnylcholine for 30 minutes. The 
reaction was terminated by adding 2 ml chloroform, 5 ml 
methanol, and 0.5 ml EDTA-KCl. The phospholipids were 
extracted as described in Materials and Methods. Each value 
represents cpms for the mean of 6 animals + the stancarc 
deviation. An asterisk (*) and two asterisks-(**) indicate 
that values from control and chlordecone exposed offspring 
are different at p<0.01 and p<0.001, respectively. 
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Appendix A 
CARBAMLYCHOLINE STIMULATED RADIOLABELED ORTHOPHOSPHATE 
INCORPORATION INTO INOSITOL PHOSPHOLIPIDS AND 
PHOSPHATIDIC ACID OF SYNAPTOSOMES FROM 
CHLORDECONE EXPOSED OFFSPRING 
DAYS TPI DPI PI PA 
17 DAYS NONCROSSFOSTERED 
Control 3701+14 2052+21 924+27 5085+208 
5 MG/KG 3457"+28 1995+42 900+20 4950+96 
15 MG/KG 3383+28* 1957+60 902+28 4815+37* 
30 MG/KG 3201"+14** 1940+21 890"+27 4680"+64** 
CROSSFOSTERED 
Control 3840+30 2090+42 918+10 5130+127 
5 MG/KG 3712"+31 2033"+60 900"+30 4890+115 
15 MG/KG 3488"+48* 1977"+20 906+"17 4770+"54* 
30 MG/KG 3424"+30** 1920+"39 894+"9 4725+36** 
24 DAYS NONCROSSFOSTERED 
Control 4576+65 2432+60 1012+28 5940+132 
5 MG/KG 4320+64** 2128"+63** 980+"16 5620+66* 
15 MG/KG 4064+14** 2014"+41** 932+26** 5400+34** 
30 MG/KG 3648"+42** 1920+80** 910+35** 5030+60** 
- -CROSSFOSTERED 
Control 4704+28 2470+61 1038+16 5985+54 
~ !'·~ /K~ 4352+40** 2242+21** 985+25 5805+63* ::l "'"" \ \..:; 
15 MG/KG 3980+26** 2055+63** 924+15** 5490+60** 
30 MG/KG 3744"+41** 1980"+41* 906"+17** 5040+32** 
31 DAYS NONCROSSFOSTERED 
Control 4672+63 2460+40 1056+28 6210+54 
5 MG/:KG 4128"+32** 2300+41* 980"+10* 5808+63* 
15 MG/KG 3872+15** 2160+63** 940+15** 5490+60** 
30 MG/KG 3616+"45** 2030+45** 920"+9** 5040+32** 
CROSSFOSTERED 
Control 4768+54 2530+84 1082+15 6345+122 
5 MG/KG 4192+26** 2337"+20*' 995+"16** 5762"+133* 
15 MG/KG 4061+27** 2185+41*'* 950+10** 5614+"85** 
30 MG/KG 3712+12** 2050+21** 925+16** 5120+"87** 
3 MOK'I'E CROSSFOSTERED 
Control 4736+51 2570+65 1074+15 6390+203 
15 MG/KG 4064+48** 2250+63** 983"+23** 5535+66** 
9 MO~'I'E CROSSFOSTERED 
Cor.tro2 4672+26 2500+88 1064+16 6170+124 
15 MG/KG 4128+30** 2280+44** 1003"+14** 5563+130** 
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Appendix B. Effects of carbarnylcholine and atropine on 32 P 
orthophosphate incorporation into inositol phospholipids and 
phosphatidic acid of synaptosomes from chlordecone exposed 
offspring. Synaptosomes from control and chlordecone 
exposeo offspring were preincubatec with radiolabeled 
orthophosphate for 1 hour. The prelabeled synaptosomes were 
incubated with atropine for 5 minutes. Half of these were 
then incubated with carbamylcholine for 30 ·minutes. The 
reaction was terminated by adding 2 ml chloroform, 5 ml 
methanol, and 0.5 ml EDTA-KCl. The phospholipids were 
extracted as described in Materials and Methods. Each value 
represents the percent stimulation over control of 6 animals 
+ the standard deviation. 
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Appendix B 
EFFECTS OF CARBAMYLCHOLINE AND ATROPINE ON 32p-ORTHOPHOSPHATE 
INCORPORATION INTO INOSITOL PHOSPHOLIPIDS AND 
PHOSPHATIDIC ACID OF SYNAPTOSOMES FROM 
CHLORDECONE EXPOSED OFFSPRING 
DAYS TPI DPI PI PA 
17 DAYS CARBAMYLCHOLINE + ATROPINE 
Control 103+3 103+1 102+2 100+1 
5 MG/KG 102+2 101+3 100+1 101+2 
15 MG/KG 102+2 104"+2 103+1 100+2 
30 MG/KG 102+3 99+2 100+3 99+"2 
ATROPINE 
Control 99+3 98+2 97+2 99+2 
5 MG/KG 97+2 95"+3 99+1 97+1 
15 MG/KG 95+1 99"+1 98+3 97+1 
30 MG/KG 96+3 99+2 96+"3 99+2 
24 DAYS CARBAMYLCHOLINE + ATROPINE 
Control 103+2 99+2 103+3 102+3 
5 MG/KG 102+2 99"+3 100+2 102+2 
15 MG/KG 100+3 97+3 99+2 103+1 
30 MG/KG 99+3 99+1 98+2 100+3 
ATROPINE 
Control 101+2 97+2 98+3 97+1 
5 MG/KG 100+2 97+2 96"+2 97"+2 
15 MG/KG 100+3 99+2 99"+3 97+1 
30 MG/KG io1+2 96+1 98+1 98+2 
31 DAYS CARBAMYLCHOLINE + ATROPINE 
Control 102+2 99+1 99+2 100+3 
5 MG/KG 103+3 96"+2 97+2 98+3 
15 MG/KG 100+2 98"+2 97+3 99"+2 
30 MG/KG 1C11+2 96"+3 98+2 98"+1 
ATROPINE 
Control 100+2 98+3 97+1 97+3 
5 MG/KG 101+3 99"+2 98"+1 98"+2 
15 .MG/KG 99+1 97+3 97+1 96+3 
30 MG/KG 100+2 99"+2 95+3 98+1 
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APPENDIX C 
DOPAMINE STIMULATED RADIOLABELED ORTHOPHOSPHATE 
INCORPORATION INTO INOSITOL PHOSPHOLIPIDS AND 
PHOSPHATIDIC ACID OF SYNAPTOSOMES FROM 
CHLORDECONE EXPOSED OFFSPRING 
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DAYS TPI DPI PI PA 
17 DAYS 
Control 3860+46 2250+63 982+27 549 0+ 94 
5 MG/KG 3750"+29 2155"+42 920"+16 4980+"120 
15 MG/KG 3470"+15** 2070"+21** 930"+9* 4870"+45** 
30 MG/KG 3425"+43** 1995"+43** 910"+20** 4850+"97** 
24 DAYS 
Control 4170+36 2430+4 3 1030+28 5810+145 
5 MG/KG 4063"+21 2240+21** 960"+10* 5570"+90** 
15 MG/KG 3760"+34** 2215+"40** 930"+18** 5250+87** 
30 MG/KG 3490"+30** 2090+62** 920"+16** 4960"+85** 
31 DAYS 
Control 4550+46 25 02+4 l 1034+8 6550+145 
5 MG/KG 4350+30* 2380+39** 987+17* 5 70 0+ 44 ** 
15 MG/KG 4030"+19** 2120+63** 940+9** 5680+40** 
30 MG/KG 3670+28** 2040+42** 920"+18** 5220+86** 
Synaptosomes from control and chlordecone exposed off spring 
were preincubated with radiolabeled orthophosphate for 1 
hour. The prelabeled synaptosomes were then stimulated with 
dopamine for 30 minutes. The reaction was terminated by 
adding 2 ml chloroform, 5 ml methanol, and 0.5 ml EDTA-KCl. 
The phospholipids were extracted as described in Materials 
ano Metho~s. Each val~e represents cpms for the mean of E 
animals +the standard deviation. An asterisk (*) and twc 
asterisks (**) indicate that values from control and 
chlordecone exposed offspring are different at p<0.01 and 
p<0.001, respectively. 
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Appendix D. Effects of dopamine and haloperidol on 32 P 
orthophosphate incorporation into inositol phospholipids and 
phosphatidic acid of synaptosomes from chlordecone exposed 
offspring. Synaptosomes from control and chlordecone 
exposed off spring were preincubated with radiolabeled 
orthophosphate for 1 hour. The prelabeled synaptosomes were 
incubated with haloperidol for 5 minutes. Half of these 
were then incubated with dopamine for 30 minutes. The 
reaction was terminated by adding 2 ml chloroform, 5 ml 
methanol, and 0.5 ~l EDTA-KCl. The phospholipids were 
extracted as 6escr10e6 in Materials and Methods. Each value 
represents the mean of 6 animals ± the standard deviation. 
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APPENDIX D 
DOPAMINE AND HALOPERIDOL STIMULATED 32P-ORTHOPHOSPHATE 
INCORPORATION INTO INOSITOL PHOSPHOLIPIDS AND 
PHOSPHATIDIC ACID OF SYNAPTOSOMES FROM 
CHLORDECONE EXPOSED OFFSPRING 
DAYS TPI DPI PI PA 
17 DAYS DOPAMINE + HALOPERIDOL 
Control 105+3 103+2 104+1 105+3 
5 MG/KG 104+1 101+1 105+1 102+1 
15 MG/KG 102+3 100+2 106+3 103+2 
30 MG/KG 100+2 97+2 102+2 98+1 
HALOPERIDOL 
Control 97+2 97+1 99+2 99+2 
5 MG/KG 98+1 94+2 98+1 97+1 
15 MG/KG 94+2 96"+2 98"+2 97+1 
30 MG/KG 96+2 98"+1 97+1 99+2 
24 DAYS DOPAMINE + HALOPERIDOL 
Control 103+2 99+2 103+3 102+3 
5 MG/KG 102+2 99+3 100+2 102+2 
15 MG/KG 100+3 97+3 99"+2 103+1 
30 MG/KG 99+3 99+1 98+2 100+3 
HALOPERIDOL 
Control l 01 +2 91 +2 98+3 97+~ 
5 MG/KG 100+2 97+2 96+2 97+2 
15 MG/KG 100+3 99+2 99+3 97+1 
30 MG/KG 101+2 96+1 98+1 98+ 2 
31 DAYS DOP&•1INE + HALOPERIDOL 
Control 104+1 99+1 99+2 100+3 
5 MG/KG 101+3 96+2 97+2 9 8+3 
15 MG/KG 102+1 98+2 97+3 99+2 
30 MG/KG 103+2 96+3 98+2 98"+1 
HALOPERIDOL 
Control 100+2 98+3 97+1 97+3 
5 MG/KG 101+3 99+2 98"+1 98"+2 
15 MG/KG 99+1 97+3 97"+1 96"+3 
30 MG/KG 100+2 99+2 95"+3 98+1 
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APPENDIX E 
NORADRENALINE STIMULATED RADIOIABELED ORTHOPHOSPHATE 
INCORPORATION INTO INOSITOL PHOSPHOLIPIDS AND 
PHOSPHATIDIC ACID OF SYNAPTOSOMES FROM 
CHLORDECONE EXPOSED OFFSPRING 
DAYS TPI DPI PI PA 
17 DAYS 
Control 4320+46 2223+16 999+18 5625+42 
5 MG/KG 4064+21* 2105+10 968+9 5265"+85* 
15 MG/KG 3872+20** 2052+9*"" 941+10* 4950+88** 
30 MG/KG 3680+44** 2014+18** 914+11** 4725+40** 
24 DAYS 
Control 4960+63 2394+10 1047+28 6075+123 
5 MG/KG 4704+42* 2204"+11** 1020+9 5670"+87* 
15 MG/KG 4352+21** 2166+36** 950+18** 5445+46** 
30 MG/KG 3872+40** 2109"+23** 924"+17** 5130+92** 
31 DAYS 
Control 5185+62 2546+34 1117+8 6435+132 
5 .MG/KG 4768+40** 2375"+36** 1038+16** 6040+79** 
15 r.:G/KG 4448+60** 2299+21** 1003+26** 5895"+83** 
30 .MG/KG 3936"+41** 2185"+11** 977+9** 5535"+132** 
Synaptosornes from control and chlordecone exposed off spring 
were preincubated with radiolabeled orthophosphate for 1 
hour. The prelabeled synaptosomes were then stimulated with 
noradrenaline for 30 minutes. The reaction was terminated 
by adding 2 ml chloroform, 5 ml methanol, and 0.5 ml EDTA-
KCl. The phospholipids were extracted as described i~ 
.Materials and Methods. Each value represents cpms for the 
mean of 6 animals + the standard deviation. An asterisk (*) 
and two asterisks (**) indicate that values from control and 
chlordecone exposed offspring are different at p<0.01 and 
p<0.001, respectively. 
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Appendix F. Effects of noradrenaline and regitine on 32 P 
orthophosphate incorporation into inositol phospholipids and 
phosphatidic acid of synaptosomes from chlordecone exposed 
offspring. Synaptosomes from control and chlordecone 
exposed offspring were preincubated with radiolabeled 
orthophosphate for 1 hour. The prelabeled synaptosomes were 
incubated with regitine for 5 minutes. Half of these were 
then incubated with noradrenaline for 30 minutes. The 
reaction was terminated by adding 2 ml chloroform, 5 ml 
methanol, and 0.5 ml EDTA-KCl. The phospholipids were 
extracted as described in Materials and Methods. Each value 
represents the mean of 6 animals + the standard deviation. 
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APPENDIX F 
EFFECTS OF NORADRENALINE AND REGITINE ON 32 P-ORTHOPHOSPHATE 
INCORPORATION INTO INOSITOL PHOSPHOLIPIDS AND 
PHOSPHATIDIC ACID OF SYNAPTOSOMES FROM 
CHLORDECONE.EXPOSED OFFSPRING 
DAYS TPI DPI PI PA 
17 DAYS NORADRENALINE + REGITINE 
Control 106+1 102+2 104+2 102+3 
5 MG/KG 103+1 100+2 103+1 103"+1 
15 MG/KG 101+2 101+2 103+1 103"+2 
30 MG/KG 102+1 99+1 102+2 99+1 
REGITINE 
Control 99+1 98+1 97+2 99+2 
5 MG/KG 99+2 95+2 99"+1 96+1 
15 MG/KG 97+3 96+2 98+2 97+1 
30 MG/KG 96+2 98+1 96+1 98+2 
24 DAYS NORADRENALINE + REGITINE 
Control 105+1 96+2 103+3 104+3 
5 MG/KG 104+2 99+2 102+2 101+3 
15 MG/KG 103+2 101"+3 99+2 102+2 
30 MG/KG 99+3 100+1 98+2 100+1 
REGITINE 
Control 101+2 97+2 98+3 97+1 
5 MG/KG 100+2 97+2 96"+2 97+2 
15 MG/KG 100+3 99+2 99+3 97+1 
30 MG/KG 101+2 96+1 98"+1 98+2 
31 DAYS NORADRENALINE + REGITINE 
-Control 104+1 99+1 99+2 100+3 
5 MG/KG 101+3 96+2 97"+2 98+3 
15 MG/KG 102+1 98+2 97+3 99+2 
30 MG/KG 103+2 96+3 98+2 98+1 
REGITJNE 
Control 100+2 98+3 97+1 97+3 
5 MG/KG 101+3 99+2 98+1 98+2 
15 MG/KG 99+1 97+3 97"+1 96+3 
30 MG/KG 100+2 99+2 95+3 98+1 
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APPENDIX G 
SEROTONIN STIMULATED RADIOLABELED ORTHOPHOSPHATE 
INCORPORATION INTO INOSITOL PHOSPHOLIPIDS AND 
PHOSPHATIDIC ACID OF SYNAPTOSOMES FROM 
CHLORDECONE EXPOSED OFFSPRING 
DAYS TPI DPI PI PA 
17 DAYS 
Control 4800+62 2850+41 1117+18 5625+122 
5 MG/KG 4384+30** 2603+21** 968"+17 5265"+88* 
15 MG/KG 4128+32** 2451+20** 941+8* 4950+130** 
30 MG/KG 3840"+60** 2280+42** 915"+9** 4725"+46** 
24 DAYS 
Control 4864+93 2888+63 1126+28 5400+126 
5 MG/KG 4768"+66 2831+41** 1047"+17** 504 0+89 ** 
15 MG/KG 4448"+97** 2641+66** 976+19** 4950+120** 
30 MG/KG 4064+88** 2413"+65** 950+15** 4680+92** 
31 DAYS 
Control 5216+88 3097+60 1151+8 6615+132 
5 MG/KG 4832+63** 2869"+41** 1056"+16** 6165+82** 
15 MG/KG 4544+91** 2 6 9 8 +6 2 * * 1030"+25** 5580+87** 
30 MG/KG 4065+65** 2432+39** 950"+7** 5130"+136** 
Synaptosomes from control and chlordecone exposed off spring 
were preincubated with radiolabeled orthophosphate for 1 
hour. The prelabeled synaptosornes were then stimulated with 
serotonin for 30 minutes. The reaction was terminated by 
adding 2 ffil chloroform, 5 ml methanol, and 0.5 ml EDTA-YCJ. 
The phospholipids were extracted as described in Materials 
and Methods. Each value represents cprns for the mean of 6 
animals +the standard deviation. An asterisk (*) and t~o 
asterisks (**) indicate that values from control and 
chlordecone exposed offspring are different at p<0.01 ano 
p<0.001, respectively. 
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APPENDIX H 
HISTAMINE STIMULATED RADIOIABELED ORTHOPHOSPHATE 
INCORPORATION INTO INOSITOL PHOSPHOLIPIDS AND 
PHOSPHATIDIC ACID OF SYNAPTOSOMES FROM 
CHL9RDECONE EXPOSED OFFSPRING 
DAYS TPI DPI PI PA 
17 DAYS 
Control 3872+62 2128+ 20 959+18 4905+132 
5 MG/KG 3360"+30* 2033+"42** 915"+17* 4900"+84 
15 MG/KG 3328"+66** 1995+"21** 906"+8* 4680"+46* 
30 MG/KG 3296"+68** 1938"+18 ** 888+"7** 4590"+92** 
24 DAYS 
Control 3872+88 2204+21 1038+9 5355+92 
5 MG/KG 3744"+62* 209 0+20 '** 976"+19** 5085"+47** 
15 MG/KG 3552"+30** 2052"+43** 941"+10** 4950"+44** 
30 MG/KG 3424"+31** 1950"+20** 915"+10** 4725"+88** 
31 DAYS 
Control 4160+84 2338+65 1110+10 5435+46 
5 MG/KG 3872"+34** 22 4 0+21 * 1020+22** 5040"+90** 
15 MG/KG 3744"+30** 2166"+43** 98 6"+9* * 4950+40** 
30 MG/KG 3552"+66** 2050"+44** 941"+8** 4860"+42** 
Synaptosomes from control and chlordecone exposed off spring 
were preincubated with radiolabelea orthophosphate for 1 
hour. The prelabeled synaptosomes were then stimulated with 
histamine for 30 minutes. The reaction was terminated by 
adding 2 rr.l chloroform, 5 ml methanol, and 0.5 rr.l EDTA-KCl. 
The phospholipids were extracted as described in Materials 
and Methods. Each value represents cprns for the mean of 6 
animals + the standard deviation. An asterisk (*) and two 
asterisks (**) indicate that values from control and 
chlordecone exposed offspring are different at p<0.01 and 
p<0.001, respectively. 
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Appendix I . Effects of hi~tamine and bentazole on 32 P 
orthophosphate incorporation into inositol phospholipids and 
phosphatidic acid of synaptosomes from chlordecone exposed 
offspring. Synaptosomes from control and chlordecone 
exposed offspring were preincubated with radiolabeled 
orthophosphate for 1 hour. The prelabeled synaptosomes were 
incubated with bentazole for 5 minutes. Half of these were 
then incubated with histamine for 30 minutes. The reaction 
was terminated by adding 2 ml chloroform, 5 ml methanol, and 
0.5 ml EDTA-KCl. The phospholipids were extracted as 
described in Materials and Methods. Each value represents 
the mean of 6 animals + the standard deviation. 
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APPENDIX I 
EFFECTS OF HISTAMINE AND BENTAZOLE ON 32 P-ORTHOPHOSPHATE 
INCORPORATION INTO INOSITOL PHOSPHOLIPIDS AND 
PHOSPHATIDIC ACID OF SYNAPTOSOMES FROM 
CHLORDECONE EXPOSED OFFSPRING 
DAYS TPI DPI PI PA 
17 DAYS HISTAMINE + BENTAZOLE 
Control 109+1 110+2 104+2 109+3 
5 MG/KG 106+1 107+2 104+1 107"+1 
15 MG/KG 104+2 104+2 103+1 105+2 
30 MG/KG 102+1 102+1 100+2 101"+1 
BENTAZOLE 
Control 100+1 101+1 98+2 102+2 
5 MG/KG 101+2 99+"2 100"+1 101+1 
15 MG/KG 101+3 100+2 96"+2 97"+1 
30 MG/KG 97+2 99"+1 94+1 96+2 
24 DAYS HISTAMINE + BENT AZ OLE 
Control 120+1 113+2 115+3 115+3 
5 MG/KG 118+2 111+2 111+2 112+3 
15 MG/KG 111+2 107+3 100+2 109"+2 
30 MG/KG 108"+3 103+1 103"+2 104"+1 
BENTAZOLE 
Control 102+2 100+2 97+3 100+1 
5 MG/KG 98+2 100+2 99"+2 99+2 
15 MG/KG 101+3 98+2 101+3 101+1 
30 MG/KG 100+2 101+1 98+1 99+2 
31 DAYS HISTAMINE + BENTAZOLE 
Control 128+1 119+1 120+2 119+3 
5 MG/KG 120+3 116"+2 118+2 116"+3 
15 MG/KG 114+1 111+2 114"+3 112+2 
30 MG/KG 108+2 105+3 106"+2 105+1 
BENTAZOLE 
Control 96+2 99+3 100+1 97+3 
5 PPM 97"+3 99"+2 101+1 96"+2 
15 PPM 96+1 97+3 99"+1 98+3 
30 PPM 97+2 99"+2 100+3 97+1 
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